
<html lang="en"     class="pb-page"  data-request-id="9285e2a0-1cd2-4340-9b72-b38bd19764ea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400474r;issue:issue:10.1021/jmcmar.2013.56.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)" /></meta><meta name="dc.Creator" content="Wei  Liu" /></meta><meta name="dc.Creator" content="Bing  Yu" /></meta><meta name="dc.Creator" content="Gang  Xu" /></meta><meta name="dc.Creator" content="Wei-Ren  Xu" /></meta><meta name="dc.Creator" content="Mignon L.  Loh" /></meta><meta name="dc.Creator" content="Li-Da  Tang" /></meta><meta name="dc.Creator" content="Cheng-Kui  Qu" /></meta><meta name="dc.Description" content="Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are associated with Noonan syndrome, childhood leukemias, and sporadic solid tumors. Virtual screening combined with experimental assa..." /></meta><meta name="Description" content="Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are associated with Noonan syndrome, childhood leukemias, and sporadic solid tumors. Virtual screening combined with experimental assa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400474r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400474r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400474r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400474r" /></link>
        
    
    

<title>Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400474r" /></meta><meta property="og:title" content="Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0008.jpeg" /></meta><meta property="og:description" content="Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are associated with Noonan syndrome, childhood leukemias, and sporadic solid tumors. Virtual screening combined with experimental assays was performed to identify inhibitors of SHP2 from a database of natural products. This effort led to the identification of cryptotanshinone as an inhibitor of SHP2. Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM. Fluorescence titration experiments confirmed that it directly bound to SHP2. Enzymatic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor. This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions. Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor. Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-associated malignancies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400474r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400474r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400474r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400474r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400474r&amp;href=/doi/10.1021/jm400474r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7212-7221</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400385r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400624b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (<i>PTPN11</i>)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Liu">Wei Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Yu">Bing Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Xu">Gang Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Ren++Xu">Wei-Ren Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mignon+L.++Loh">Mignon L. Loh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Da++Tang">Li-Da Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Kui++Qu">Cheng-Kui Qu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California, San Francisco, San Francisco, California 94122, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 216-368-3361. Fax: 216-368-1166. E-mail: <a href="/cdn-cgi/l/email-protection#d0b3a8a1e690b3b1a3b5feb5b4a5"><span class="__cf_email__" data-cfemail="43203b327503202230266d262736">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400474r&amp;href=/doi/10.1021%2Fjm400474r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7212–7221</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 19, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 April 2013</li><li><span class="item_label"><b>Published</b> online</span>4 September 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400474r" title="DOI URL">https://doi.org/10.1021/jm400474r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7212%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWei%2BLiu%252C%2BBing%2BYu%252C%2BGang%2BXu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D18%26contentID%3Djm400474r%26title%3DIdentification%2Bof%2BCryptotanshinone%2Bas%2Ban%2BInhibitor%2Bof%2BOncogenic%2BProtein%2BTyrosine%2BPhosphatase%2BSHP2%2B%2528PTPN11%2529%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7221%26publicationDate%3DSeptember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400474r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2166</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400474r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Wei-Ren&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Mignon&quot;,&quot;last_name&quot;:&quot;L. Loh&quot;},{&quot;first_name&quot;:&quot;Li-Da&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Cheng-Kui&quot;,&quot;last_name&quot;:&quot;Qu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7212-7221&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400474r&quot;},&quot;abstract&quot;:&quot;Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are associated with Noonan syndrome, childhood leukemias, and sporadic solid tumors. Virtual screening combined with experimental assays was performed to identify inhibitors of SHP2 from a database of natural products. This effort led to the identification of cryptotanshinone as an inhibitor of SHP2. Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM. Fluorescence titration experiments confirmed that it directly bound to SHP2. Enzymatic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor. This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions. Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor. Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400474r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400474r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400474r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400474r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400474r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400474r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400474r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400474r&amp;href=/doi/10.1021/jm400474r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400474r" /></input><a href="/doi/pdf/10.1021/jm400474r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26pmid%3D23957426%26genre%3Darticle%26aulast%3DLiu%26date%3D2013%26atitle%3DIdentification%2Bof%2BCryptotanshinone%2Bas%2Ban%2BInhibitor%2Bof%2BOncogenic%2BProtein%2BTyrosine%2BPhosphatase%2BSHP2%2B%2528PTPN11%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D18%26spage%3D7212%26epage%3D7221%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jmcmar.2013.56.issue-18/production/jmcmar.2013.56.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Activating mutations of <i>PTPN11</i> (encoding the SHP2 phosphatase) are associated with Noonan syndrome, childhood leukemias, and sporadic solid tumors. Virtual screening combined with experimental assays was performed to identify inhibitors of SHP2 from a database of natural products. This effort led to the identification of cryptotanshinone as an inhibitor of SHP2. Cryptotanshinone inhibited SHP2 with an IC<sub>50</sub> of 22.50 μM. Fluorescence titration experiments confirmed that it directly bound to SHP2. Enzymatic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor. This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions. Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in <i>PTPN11</i> were found to be sensitive to this inhibitor. Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat <i>PTPN11</i>-associated malignancies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Germline or somatic mutations in protein tyrosine phosphatase (PTP) <i>PTPN11</i> (SHP2) that cause hyperactivation of SHP2 catalytic activity have been identified in patients with developmental disorder Noonan syndrome (∼50%) and various childhood leukemias, including juvenile myelomonocytic leukemia (JMML) (∼35%), myelodysplastic syndrome (∼10%), B cell acute lymphoblastic leukemia/lymphoma (∼7%), and acute myeloid leukemia (AML) (∼4%).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> In addition, activating mutations of <i>PTPN11</i> have been found in adult AML as well as sporadic solid tumors, such as lung cancer, colon cancer, melanoma, neuroblastoma, and hepatocellular carcinoma.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> In JMML, <i>PTPN11</i> mutations and other JMML-associated <i>Ras</i>, <i>c-CBL</i>, or <i>NF1</i> mutations are mutually exclusive.<a onclick="showRef(event, 'ref1 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref8 ref9">(1, 8, 9)</a> Remarkably, recent studies have demonstrated that single <i>PTPN11</i> gain-of-function mutations are sufficient to induce Noonan syndrome, JMML-like myeloproliferative disease, and acute leukemias in mice.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> The direct connection between activating mutations of <i>PTPN11</i> and these diseases makes SHP2 an attractive target for mechanism-based therapeutics.</div><div class="NLM_p">SHP2 encoded by the <i>PTPN11</i> gene is a nonreceptor PTP, which contains two N-terminal Src homology 2 (SH2) domains, one PTP domain, and a C-terminal tail.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In the basal state, the N-terminal SH2 (N-SH2) domain blocks the catalytic site in the PTP domain until tyrosine-phosphorylated partners bind to SHP2.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><i>PTPN11</i> mutations found in Noonan syndrome, leukemias, and tumors disrupt the autoinhibition between N-SH2 and PTP domains, leading to gain-of-function by allowing constitutive access to the catalytic site of the enzyme.<a onclick="showRef(event, 'ref4 ref16'); return false;" href="javascript:void(0);" class="ref ref4 ref16">(4, 16)</a> SHP2 is widely expressed and involved in multiple cell signaling processes, such as the Ras-Erk, PI3K-Akt, Jak-Stat, and NF-κB pathways.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Although it is a positive regulator of signaling cascades initiated by growth factors/cytokines and extracellular matrix proteins,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> the mechanisms of SHP2 function are still not completely known, and especially the molecular basis for the pivotal role of its catalytic activity in cell signaling pathways remains to be further understood. Thus, specific and potent SHP2 inhibitors with pharmacological properties are greatly needed for the research on SHP2 functions and the development of new drugs that ultimately serve as treatments for <i>PTPN11</i>-associated malignancies.</div><div class="NLM_p last">Identification of a structurally diverse set of lead compounds could lead to the development of novel SHP2 inhibitors. The availability of three-dimensional (3D) crystal structural information on SHP2<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> makes it possible to apply target-based computer-aided drug design (CADD) methods to find SHP2 inhibitors. As natural products have certain advantages over novel compounds for drug discovery,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in the present study, using CADD screening against the 3D structure of SHP2 followed by experimental assays, we have screened ∼10 000 natural products, including herbal medicine currently used in the clinic. We have identified that cryptotanshinone inhibits SHP2 catalytic activity. Moreover, biological assays verify that it is efficacious in blocking SHP2-mediated signaling and cellular functions, especially the growth of <i>PTPN11</i> mutant mouse and human leukemia cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> CADD in Silico Screening and Compound Selection</h3><div class="NLM_p">To expedite identification of SHP2 inhibitors that may be directly used for the treatment of <i>PTPN11</i>-associated malignancies, we chose to screen a database of natural products using CADD screening based on the 3D structure of the SHP2 protein. A structural alignment between SHP2 and the highly related SHP1 phosphatase was performed in order to search for a potential drug-docking site in the SHP2 catalytic domain that would be specific for that protein. Not surprisingly, the catalytic pockets were almost identical in SHP2 and SHP1 except four residues, i.e., Lys358, Arg362, Lys364, and Ser 365 in SHP2, which correspond to Arg352, Lys356, Arg358, and Asn359 in SHP1 (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>). This led to the identification of a putative site in the entrance of the SHP2 catalytic cleft that appeared to be different from that in SHP1 in both structure and amino acid composition. Ligands bind to those amino acids which in the periphery of the active center through hydrophobic stabilization or hydrogen-bond (H-bond) interactions could mask the catalytic signature residues (Cys459 and Ser460), and this represents a logical place for active site-directed screening.</div><div class="NLM_p last">In silico screening was carried out against a library of ∼10 000 small molecular weight natural products targeting the peripheral site in the entrance of the SHP2 catalytic cleft, and the primary screening should meet the following criteria: (1) The nearest distance from a compound must be within 5 Å of residue Cys459 or Ser460 in SHP2 and beyond 5 Å of residue Cys453 or Ser454 in SHP1. (2) The interaction energy between a compound and one of the hydrophobic residues in SHP2 must be more than 1 kJ/mol. The obtained complex structures were refined using Embrace method of MacroModel for secondary screening. After the primary screening with Glide Module and the secondary screening with MacroModel, top 200 molecules with interaction energy less than −50 kJ/mol were selected for further analyses, such as binding modes and diversity analysis. The further selection process was mainly based on the distributions of three indexes of each compound including principle moment of inertia, dipole moment, and molecular weight. The indexes were normalized and divided into 10 parts, and each dot represented a compound in the grid system of three indexes. Compounds in the same lattice were clustered into a group. One or two compounds were selected from each group. As a result, a total of 43 natural products were selected and subsequently obtained from commercial sources and subjected to experimental testing.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identification of Cryptotanshinone as a Novel SHP2 Inhibitor</h3><div class="NLM_p">We screened the candidate compounds selected by CADD screening using SHP2 enzymatic assays. Among the 43 natural products, cryptotanshinone (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A and <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S2">Supporting Information Figure S2</a>), one of the major active ingredients of the traditional medicinal herbal plant <i>Salvia miltiorrhiza</i> Bunge (Danshen) that is used for the treatment of cardiovascular diseases in Asian countries, was able to inhibit SHP2 catalytic activity in enzymatic assays. To determine functional specificities of this compound, its inhibitory activities were assessed against a panel of mammalian PTPs, in particular those phosphatases that are highly expressed in hematopoietic cells. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B, cryptotanshinone inhibited the SHP2-catalyzed hydrolysis of a phosphopeptide substrate with an IC<sub>50</sub> of 22.50 μM, which was approximately 1.76-fold selective for SHP2 over its homologue SHP1, and 1.49-, 1.84-, 1.64-, 2.64-, 2.48-fold selective for SHP2 compared to PTP1B, CD45, LAR, MEG2, and TC-PTP, respectively.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of cryptotanshinone as an inhibitor of SHP2. (A) Chemical structure of cryptotanshinone. (B) Phosphatase assays were carried out using the indicated phosphatases as enzymes and a phospho-EGFR peptide as the substrate in the presence of various concentrations of cryptotanshinone, as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For IC<sub>50</sub> determinations, six concentrations of cryptotanshinone were tested. Results shown are the mean ± SEM of three independent experiments. (C) PTP activities of the SHP2 PTP domain, WT full length SHP2, and full length SHP2 E76K were determined in the presence of cryptotanshinone at the indicated concentrations using a phospho-EGFR peptide as the substrate. Experiments were repeated three times. Similar results were obtained in each. Results shown are the mean ± SEM of triplicates from one experiment. Shown on the right panel are purified recombinant proteins stained with Coomassie blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Cryptotanshinone Preferentially Inhibits the Activated Form of SHP2</h3><div class="NLM_p">In the basal state, SHP2 is autoinhibited by H-bonding of the N-SH2 domain loop to the deep pocket of the PTP domain. Tumor-associated mutations of <i>PTPN11</i> result in amino acid changes at the interphase formed by N-SH2 and PTP domains, disrupting the inhibitory interaction, leading to hyperactivation of SHP2 catalytic activity.<a onclick="showRef(event, 'ref4 ref16'); return false;" href="javascript:void(0);" class="ref ref4 ref16">(4, 16)</a> The E76K mutation, localized in the N-SH2 domain, is the most common and most active mutation found in leukemias.<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a> To further characterize the acting mechanisms of cryptotanshinone, we purified GST fusion proteins of the SHP2 PTP domain, wild-type (WT) full-length SHP2, and the full-length SHP2 E76K mutant and compared sensitivities of these SHP2 recombinant proteins to cryptotanshinone. This drug inhibited the SHP2 E76K mutant in a dose-dependent manner, with an IC<sub>50</sub> of 23.90 μM that is equal to IC<sub>50</sub> for the SHP2 PTP domain (22.50 μM). However, the IC<sub>50</sub> of cryptotanshinone for WT full-length SHP2 (45.18 μM) was 1.89-fold and 2.01-fold higher than those for the SHP2 E76K mutant and the SHP2 PTP domain, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C). The observation that WT full-length SHP2 is less sensitive to cryptotanshinone than the SHP2 PTP domain and that the SHP2 E76K mutant is more sensitive than WT full-length SHP2 to this inhibitor indicates that the closed confirmation formed between N-SH2 and PTP domains interferes with cryptotanshinone binding to SHP2 and that this compound preferentially inhibits the activated form of SHP2 with an open confirmation. To further characterize the activity of cryptotanshinone, we also tested its effects on SHP2 catalytic activity using <i>p</i>-nitrophenylphosphate (<i>p</i>NPP), a general small compound substrate for all PTPs. Similar effects were observed (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S3">Supporting Information Figure S3</a>). These results suggest that cryptotanshinone inhibits SHP2 activity likely by disrupting constitutive access to the SHP2 catalytic cleft regardless of what kinds of substrates were used. Furthermore, we performed enzymatic kinetic studies and determined <i>V</i><sub>max</sub>, <i>K</i><sub>cat</sub>, and <i>K</i><sub>m</sub> values in the absence or presence of this inhibitor. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <i>V</i><sub>max</sub> was decreased and <i>K</i><sub>m</sub> was increased by this inhibitor, suggesting that cryptotanshinone is a mixed-type inhibitor. We also tested whether the inhibition of SHP2 by cryptotanshinone is reversible by extensive washing of the enzyme–inhibitor complex. The results obtained indicate that this drug is an irreversible inhibitor (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S4">Supporting Information Figure S4</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cryptotanshinone directly binds to the SHP2 protein and functions as a mixed-type inhibitor. (A) Enzymatic kinetic analyses in the presence or absence of cryptotanshinone (25 μM) were performed using GST-SHP2 PTP (1.0 μg) as the enzyme. <i>V</i><sub>max</sub>, <i>K</i><sub>cat</sub>, and <i>K</i><sub>m</sub> values in the absence or presence of this inhibitor were determined. Results shown in the table are the mean ± SEM of three independent experiments. (B) Fluorescence titration of SHP2 was performed by increasing the concentrations of cryptotanshinone while maintaining the SHP2 protein concentration (1.0 μg). The fluorescence is plotted against the log concentration in mol/L (log [M]) for the compound. Experiments were repeated twice. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To validate that cryptotanshinone was binding directly to the SHP2 protein, we examined whether binding of the inhibitor altered the fluorescence of the SHP2 PTP domain using the fluorescence quenching assay taking advantage of the four tryptophans in the PTP domain. Of these residues, Trp248 is located 15 Å from the putative pY + 5 pocket and Trp423 located 8 Å from the phosphatase active site. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, this drug exhibited strong quenching of SHP2 fluorescence in a dose-dependent manner. These fluorescence quenching experiments imply that cryptotanshinone binds directly to SHP2, thereby attenuating its activity toward the substrates.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Effects of Cryptotanshinone on SHP2-Mediated Cell Signaling and Cellular Function</h3><div class="NLM_p">Our previous studies have demonstrated that SHP2 promotes IL-3-stimulated cell proliferation through activation of Erk, Akt, and Jak2,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and JMML patient or mouse bone marrow cells with activating mutations of <i>PTPN11</i> are hypersensitive to GM-CSF and IL-3.<a onclick="showRef(event, 'ref25 ref26 ref10 ref12 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref10 ref12 ref27">(25, 26, 10, 12, 27)</a> To characterize the effects of cryptotanshinone on SHP2-mediated cellular function, IL-3-dependent Ba/F3 cells were therefore used. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, this compound displayed significant growth inhibitory effect in Ba/F3 cells with an IC<sub>50</sub> of 17.22 μM, consistent with the overall positive role of SHP2 catalytic activity in cellular response to IL-3. To evaluate whether cryptotanshinone functions through interfering with SHP2-mediated cell signaling, we examined the effects of this inhibitor on IL-3-induced activation of Erk, Akt, and Jak2. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C, IL-3-induced activation of Erk, Akt, Jak2, and Stat5 determined by their phosphorylation levels was greatly suppressed by cryptotanshinone, and the drug functioned in a dose-dependent manner, in line with the notion that SHP2 catalytic activity is required for optimal activation of these signaling pathways triggered by IL-3.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Additionally, we found that tyrosine-phosphorylation of Gab2 (carried out by Jak2 kinase), an important adaptor protein for the PI3K-Akt pathway,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> and Gab2-SHP2 interaction in Ba/F3 cells were markedly decreased by cryptotanshinone treatment (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S5">Supporting Information Figure S5</a>). Taken together, these results imply that IL-3 signaling processes including Ras-Erk, PI3K-Akt, and Jak2-Stat5 pathways were down-regulated following the treatment with cryptotanshinone through a mechanism involving the inhibition of SHP2 catalytic activity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cryptotanshinone inhibits SHP2-mediated IL-3 signaling and IL-3-induced cellular responses. (A) Ba/F3 cells were cultured in IL-3 (1.0 ng/mL) containing medium supplemented with cryptotanshinone at the indicated concentrations or control DMSO. Cell numbers were determined 48 h later using the one solution cell proliferation assay kit. Experiments were performed three times with similar results obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment. (B) Ba/F3 cells were deprived of IL-3 overnight. Cells were treated with cryptotanshinone (20 μM) for 3 h and then stimulated with IL-3 (1.0 ng/mL) for the indicated times. (C) Ba/F3 cells were deprived of IL-3 overnight. Cells were treated with cryptotanshinone at the indicated concentrations for 3 h and then stimulated with IL-3 (1.0 ng/mL) for 10 min. Whole cell lysates were prepared. The levels of p-Erk, p-Akt, p-Jak2, and p-Stat5 were determined by immunoblotting analyses. Blots were striped and reprobed with anti-Erk, anti-Akt, anti-Jak2, and anti-Stat5 antibodies to check for protein loading. Experiments were repeated three times. Representative results from one experiment are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Effects of Cryptotanshinone Are Decreased in SHP2 Knockdown Cells</h3><div class="NLM_p">To validate that the effects of cryptotanshinone on cell growth were mediated through inhibiting SHP2, we tested cryptotanshinone in SHP2 knockdown cells. HeLa cells were transfected with SHP2-specific siRNA and then treated with cryptotanshinone or DMSO for 24 h. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, proliferation of control cells was decreased by the SHP2 inhibitor, consistent with the positive role of SHP2 in growth factor signaling. SHP2-depleted cells were much less sensitive to this drug, suggesting that SHP2 is a main target of cryptotanshinone. However, since the growth of SHP2-depleted cells was still decreased by cryptotanshinone, these experiments additionally indicate that cryptotanshinone may have additional targets.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of cryptotanshinone are decreased in SHP2 knockdown cells. HeLa cells were transfected with control or SHP2 siRNA (400 pmol/8.0 × 10<sup>5</sup> cells). Forty-eight hours later, transfected cells were treated with cryptotanshinone at the indicated concentrations. Cell numbers were determined 24 h after the treatment. Cryptotanshinone or DMSO-treated knock-down and control cells were normalized against untreated knock-down and controls cells, respectively. SHP2 levels in knockdown and control cells were analyzed by immunoblotting analyses with anti-SHP2 antibody. Blots were stripped and reprobed with anti β-actin antibody to monitor protein loading. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Mutant Cells Harboring Hyperactivated SHP2 Are More Sensitive to Cryptotanshinone</h3><div class="NLM_p">We next assessed effects of cryptotanshinone on mutant cells with a tumor-associated <i>PTPN11</i> activating mutation (<i>PTPN11</i><sup>E76K/+</sup>). As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, treatment of both WT and <i>PTPN11</i><sup><i>E76K/+</i></sup> mouse embryonic fibroblasts with the compound decreased cell growth. Intriguingly, <i>PTPN11</i><sup><i>E76K/+</i></sup> mutant cells were more sensitive to SHP2 inhibition. Previous studies have shown that bone marrow cells from JMML patients or mice with activating mutations of <i>PTPN11</i> display a characteristic hypersensitive growth pattern, resulting in greater production of granulocyte-macrophage colonies in response to GM-CSF in CFU assays.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> We next assessed whether cryptotanshinone could inhibit colony formation and proliferation of mutant hematopoietic cells with <i>PTPN11</i> activating mutations. As previously reported, compared to those of WT counterparts, myeloid progenitors from <i>PTPN11</i><sup><i>E76K/+</i></sup> mice showed greatly increased responses to GM-CSF.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, colony-forming capabilities of mutant SHP2-expressing progenitors were significantly reduced over a range of cryptotanshinone concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Furthermore, colony formation of myeloid blasts from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation was exquisitely sensitive to cryptotanshinone (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Consistent with these data, the total cell number of JMML cells cultured in GM-CSF-containing medium was greatly decreased by the treatment of this inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D). These findings suggest that a low concentration of cryptotanshinone is sufficient to overcome the dominant effects of SHP2 gain-of-function mutations in primary myeloid progenitors, confirming that human JMML might be addicted to oncogenic <i>PTPN11</i> mutations. Additionally, we found that treatment of U973 human lymphoma cells harboring an activating mutation (G60R) of <i>PTPN11</i> and of H661 human lung cancer cells carrying another activating mutation (N58S) of <i>PTPN11</i> with the compound decreased cell proliferation in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>E). A robust induction of apoptosis was observed in cryptotanshinone-treated U937 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>F) while cryptotanshinone-treated H661 cells showed G1-S arrest (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S6">Supporting Information Figure S6</a>), consistent with the positive role of SHP2 in the cell cycle progression and cell survival. The difference in the responses to SHP2 inhibition in different cell lines might be due to other different genetic mutations in these cell lines. Overall, these results support that cryptotanshinone sensitively inhibits mutant cells harboring activating mutations of <i>PTPN11</i> and suggest that this drug may be useful for the treatment of <i>PTPN11</i> mutation-associated malignancies.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mutant cells harboring hyperactivated SHP2 are more sensitive to cryptotanshinone. (A) WT and <i>PTPN11</i><sup><i>E76K/+</i></sup> MEFs were cultured in 10% FBS-containing DMEM supplemented with cryptotanshinone (20 μM). Cell numbers were determined using the one solution cell proliferation assay kit. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment. (B) Bone marrow cells harvested from <i>PTPN11</i><sup><i>E76K/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> and <i>PTPN11</i><sup><i>+/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> mice were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Colonies were enumerated 7 days later and normalized against the number of colonies derived from WT control cells treated with control DMSO. Representative results from two independent experiments are shown. Data are presented as the mean ± SEM of triplicates. (C) Bone marrow cells or splenocytes from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Colonies were enumerated 14 days later and normalized against the number of colonies derived from the cells treated with DMSO. Three patient samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one patient sample. (D) Bone marrow cells or splenocytes from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation were cultured in RPMI 1640 medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Total cell numbers were determined and normalized against the number of the cells treated with DMSO. Three patient samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one patient sample. (E) Human lymphoma cell line U937 with the <i>PTPN11</i><sup><i>G60R/+</i></sup> mutation and human lung cancer cell line H661 with the <i>PTPN11</i><sup><i>N58S/+</i></sup> mutation were incubated with cryptotanshinone at the indicated concentrations for 48 h. DMSO-treated cells were included as negative controls. Cell numbers were determined using the one solution cell proliferation assay kit. Experiments were repeated three times. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one representative experiment. (F) U937 cells were incubated with cryptotanshinone at the indicated concentrations. Apoptotic cells were quantified 24 h later by FACS using an annexin V staining kit following the instructions provided by the manufacturer. Cell cycle changes were determined by propidium iodide staining followed by FACS analyses 48 h later. Experiments were performed three times. Data presented on the left panel are the mean ± SEM of three experiments. Cell cycle profiles shown on the right panel are representatives of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cryptotanshinone functioned much more effectively in primary leukemic cells from human patients even at the concentrations lower than its in vitro IC<sub>50</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D). This unexpected observation indicates that this drug may have other targets that are also important for cell proliferation. Another possibility is that metabolites of cryptotanshinone may have better activities. To test the second possibility, we determined potential effects of cryptotanshinone derivatives, i.e., tanshinone I, dihydrotanshinone, and tanshinone IIA (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A) on SHP2 activity. As demonstrated in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, indeed these three derivatives potently inhibited SHP2. The IC<sub>50</sub> of tanshinone I, dihydrotanshinone, and tanshinone IIA was 8.75-, 5.71-, and 8.69-fold lower than that of cryptotanshinone, even though these compounds showed no selectivity between SHP2 and SHP1.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of SHP2 and SHP1 by cryptotanshinone derivatives. (A) Chemical structures of tanshinone I, dihydrotanshinone, tanshinone IIA. (B) Phosphatase assays were carried out using the indicated phosphatases as enzymes and a phospho-EGFR peptide as the substrate in the presence of various concentrations of the compounds, as described in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B. For IC<sub>50</sub> determinations, five concentrations of the compounds were tested. Results shown are the mean ± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cryptotanshinone Likely Binds to the Entrance of the Active Site of SHP2</h3><div class="NLM_p last">To evaluate the binding mode between cryptotanshinone and the SHP2 PTP domain, computer docking was performed. Several docked poses with similar interaction energies were inspected. The pose with the lowest interaction energy is shown in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S7A and Figure S7B">Supporting Information Figure S7A and Figure S7B</a>, the two carbonyl oxygen atoms of cryptotanshinone direct to the H-bonding surface and the cycloalkane and the two methyl groups are surrounded by the hydrophobic surface. This molecular model predicts that cryptotanshinone binds to a specific site where the two carbonyl oxygen atoms form hydrogen bonds with Lys364 and Lys366 at the periphery of the catalytic cleft. The two H-bond lengths (O···H) are 1.850 and 1.738 Å, respectively. Also, the benzene ring structure of cryptotanshinone is almost parallel to the ring structure of Tyr279, and this aromatic π–π stacking reinforces the complex structure. These findings help explain the molecular basis of SHP2 inhibition by cryptotanshinone.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we have identified a known natural product as a SHP2 inhibitor. SHP2 is an important signaling component downstream of growth factor/cytokine receptors and cell adhesion molecules. Germline and somatic activating mutations of <i>PTPN11</i> (encoding SHP2) are associated with human diseases, such as Noonan syndrome, childhood leukemias, and solid tumors.<a onclick="showRef(event, 'ref1 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref5 ref6">(1, 4-6)</a> More importantly, these mutations play a causative role in the pathogenesis of Noonan syndrome and leukemias.<a onclick="showRef(event, 'ref10 ref11 ref12 ref27 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref27 ref30 ref31">(10-12, 27, 30, 31)</a> Thus, identification of inhibitors of the SHP2 phosphatase would greatly facilitate the development of therapeutic drugs for these diseases. Despite a great need, progress in developing selective SHP2 inhibitors is limited because of the high homology of the catalytic sites in protein tyrosine phosphatases. Using CADD database screening in combination with experimental assays, we have now identified the natural product cryptotanshinone as a SHP2 inhibitor, although it shows moderate selectivity for SHP2 versus SHP1 and other PTPs.</div><div class="NLM_p">Cryptotanshinone is one of the major active ingredients of the traditional medicinal herbal plant <i>Salvia miltiorrhiza</i> Bunge (Danshen). This drug has multiple functions and is commonly used in Asian countries to treat coronary heart disease, hyperlipidemia, acute ischemic stroke, hepatitis, chronic renal failure, and Alzheimer’s disease.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36">(32-36)</a> Recently, cryptotanshinone has become increasingly important in cancer therapy.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It has been found to inhibit cancer cell growth through blocking of the dimerization of Stat3 and by suppression of mTOR-mediated cyclin D1 expression and Rb phosphorylation.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Besides down-regulating antiapoptotic protein expression survivin and Mcl-1, cryptotanshinone induction of reactive oxygen species (ROS) activates p38/JNK and inhibits Erk1/2, leading to caspase-independent cell death in tumor cells.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Our study in this report provides the first evidence that cryptotanshinone is an inhibitor of the SHP2 phosphatase. Given the positive roles that SHP2 phosphatase plays in the signal transduction of growth factors/cytokines and cell adhesion molecules, it is quite possible that some of the functions of this drug, such as antitumor activity and antithrombosis activity, might be mediated through suppression of the catalytic activity of SHP2.</div><div class="NLM_p">It is interesting that cryptotanshinone preferentially inhibits the activated form of SHP2, which can result either from activating mutations such as E76K or from SHP2 binding to N-SH2 domain docking proteins. Since cryptotanshinone inhibits SHP2 catalytic activity toward both the pY-peptide substrate and the small molecule substrate <i>p</i>NPP, it is likely that this drug functions as designed by restricting the access of these substrates to the catalytic pocket of SHP2. This notion is supported by the mode of interaction revealed by computational modeling in which cryptotanshinone interacts with Lys364, Lys366, and Tyr279 residues at the periphery of the active site within the PTP domain. These residues most likely contribute to the binding affinity of cryptotanshinone with SHP2. Lys364 is unique to SHP2, and this residue has been shown to be critical for the binding of another inhibitor of SHP2.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">The discovery of SHP2-specific inhibitors is complicated by the extremely high homology of the catalytic core of SHP2 with those of SHP1 and other PTPs. Our initial structure-based approach was based on targeting a nonhomologous pocket in the pY-peptide binding cleft in SHP2 adjacent to the homologous catalytic site and having unique features in both amino acid composition and 3D structure.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> A few novel compounds were identified as selective inhibitors of SHP2. Using the same strategy, we also screened a database of Food and Drug Administration approved known drugs. Unfortunately, none of the 35 drugs identified in the CADD screening were able to inhibit SHP2 (data not shown). In the present study, we chose to target the catalytic site of SHP2 and screened a database of natural products that have advantages over novel compounds for drug development. This effort led us to the identification of cryptotanshinone as a SHP2 inhibitor. The IC<sub>50</sub> of cryptotanshinone for SHP2 is only 2-fold lower than that for SHP1. This is because the active site of SHP2 is highly homologous to that of SHP1. Nevertheless, cryptotanshinone may be still useful for future studies of SHP2 in solid tumors, since SHP2 is ubiquitously expressed whereas SHP1 expression is restricted to hematopoietic cells. Further medicinal chemistry studies of this natural product is necessary to establish independent intellectual property positions that will allow pharmacological validation of its effect of SHP2 inhibition for the development of analogues for preclinical and clinical studies. Additionally, cocrystallization of this inhibitor and SHP2 is required to reveal the structural bases of the binding interactions of the compound with SHP2. This will be essential for developing a SHP2-specific inhibitor in our future effort.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> CADD in Silico Screening</h3><div class="NLM_p last">Briefly, the 3D crystal structure of SHP2 was downloaded from Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>) with the code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>. The receptor structure was then prepared using Protein Prepare wizard by assigning bond orders, adding hydrogen, and deleting water. The N-SH2 domain of SHP2, which blocks the catalytic site, was removed before the molecular docking. The PTP domain was minimized with Module MacroModel using default parameters. The force field used was OPLS 2005. The solvent used was water with dielectric constant 1.0. The minimization method was PRCG with 500 maximal iterations. The docking site of the catalytic domain of SHP2 was chosen by Module site map, and then grid parameter files were produced by default method in Glide. A database of natural products (∼10 000 compounds) was used for computational calculation. The structures of compounds were sketched in Maestro and were processed using LigPrep. The chirality of each molecule was preserved. Partial charges were from OPLS 2005. Molecular docking computation was then carried out using default parameters of Glide module. The docked pose, score, interaction energy, and distance to residues of each molecule were recorded. After primary screening, the obtained complex structure was refined using Embrace method of MacroModel. The force field we used was OPLS 2005, and the convergence threshold was set to 0.05 kJ/mol. The interaction energy of optimized pose was used for further consideration. All these calculations were performed using Schrödinger 2009 software.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Reagents and Chemicals</h3><div class="NLM_p last">RPMI 1640, DMEM, IMDM, and the penicillin–streptomycin stock solution were purchased from Thermo Scientific/HyClone Laboratories (Logan, UT, USA). Fetal bovine serum (FBS) was obtained from Invitrogen (Grand Island, NY, USA). The CellTiter 96 AQueous one solution cell proliferation assay kit was purchased from Promega (Madison, WI, USA). Antibodies specific for p-Erk (E-4), Erk (C-16), Jak2 (C-20), and SHP2 (C-18) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibodies against p-Akt (Ser473), Akt, and p-Stat5 (Y694) were obtained from Cell Signaling Technology (Beverly, MA, USA). Antibody against Stat5 was purchased from BD Biosciences (San Jose, CA, USA). Antibodies specific for p-Jak2 (Tyr1007/1008) and phosphotyrosine (pY) were purchased from Millipore Corporation (Temecula, CA, USA). Goat-anti-rabbit and anti-mouse IgG horseradish peroxidase (HRP) conjugates were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA, USA). Dimethyl sulfoxide (DMSO) and other chemicals used in buffer solutions were provided by Fisher Scientific (Pittsburgh, PA, USA). Cryptotanshinone, tanshinone I, dihydrotanshinone, tanshinone IIA were obtained from Xi’an HaoXuan Bio-Tech Co., Ltd. (Xi’an, China) and dissolved in DMSO to prepare stock solutions (20 mM) for subsequent experiments. All test compounds possess a purity of ≥98% by HPLC according to the manufacturer.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Phosphatase Activity Assay</h3><div class="NLM_p last">Glutathione <i>S</i>-transferase (GST) fusion proteins of SHP2 purified in-house were used as the enzyme, and a phosphopeptide corresponding to the surrounding sequence of pTyr<sup>1018</sup> in the epidermal growth factor receptor (EGFR, Asp-Ala-Asp-Glu-Tyr[PO<sub>3</sub>H<sub>2</sub>]-Leu-Ile-Pro-Gln-Gln-Gly) was used as the substrate. The assay determines free phosphate generated by dephosphorylation of the substrate using the Malachite Green reagent (Sigma, St. Louis, MO, USA). An amount of 0.5 μg of GST-SHP2 PTP was used in the phosphatase assay for screening of SHP2 inhibitors. Initial rate conditions (0.2 mM substrate and 10 min incubation time) (<i>V</i><sub>max</sub> concentration of substrate is approximately 0.3 mM) were determined following the standard enzymatic kinetic assay and used in subsequent screening. In brief, 0.5 μg of GST-SHP2 PTP was incubated in 40 μL of assay buffer (25 mM Tris-HCl, pH 7.4, 50 mM NaCl, 5 mM DTT, and 2.5 mM EDTA) with test compounds at various concentrations at room temperature for 30 min. The substrate was then added to a final concentration of 0.2 mM. The reaction system was incubated at 30 °C for 30 min. Finally, 50 μL of Malachite Green solution was added, and OD<sub>620</sub> was measured after 10 min. The protocols for the phosphatase assays for SHP1, PTP1B, CD45, LAR, MEG2, and TC-PTP were similar, with the exception that GST-CD45 cytoplasmic domain, GST-LAR, GST-MEG2, and GST-TC-PTP enzymes purchased from Biomol International, L.P. (Plymouth Meeting, PA, USA), were used in the respective assays.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Fluorescence Titrations</h3><div class="NLM_p last">For all experiments, purified SHP2 PTP domain GST-fusion protein was diluted into 20 mM Tris-HCl, pH 7.5. Fluorescence spectra were recorded with a luminescence spectrometer LS50 (Perkin-Elmer, Boston, MA, USA). Titrations were performed by increasing the test compound concentrations while maintaining the SHP2 protein concentration at 3 μM. Contributions from background fluorescence of the inhibitor were accounted for by subtracting the fluorescence of the inhibitor alone from the protein–inhibitor solution. The excitation wavelength was 295 nm, and fluorescence was monitored from 360 to 500 nm. All reported fluorescence intensities were relative values and were not corrected for wavelength variations in detector response.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cell Proliferation Assay</h3><div class="NLM_p last">Briefly, Ba/F3 cells were seeded at a density of 5 × 10<sup>3</sup> cells/well in 96-well plates in RPMI-1640 containing 10% FBS plus recombinant mouse IL-3 (1.0 ng/mL). Cells were grown overnight and then treated with either the test compound or the same concentrations of DMSO. After incubation for 2 days, the number of viable cells was determined using a CellTiter 96 AQueous one solution cell proliferation assay kit (Promega, Madison, WI, USA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Western Blot Analysis</h3><div class="NLM_p last">Ba/F3 cells were starved in serum and cytokine-free RPMI1640 overnight before treatment with the compound and stimulation with IL-3. Stimulated cells were harvested and lysed on ice with RIPA buffer containing 50 mM Tris-HCl, pH 7.4; 1% NP-40; 0.25% Na deoxycholate; 150 mM NaCl; 1 mM EDTA; 1 mM NaF; 1 mM Na<sub>3</sub>VO<sub>4</sub>; 1 mM PMSF; and protease inhibitor cocktail (Roche, Indianapolis, IN, USA). Equivalent amounts of protein (50 μg) were resolved on 10% SDS–PAGE and transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 2% BSA in TBS-T [20 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 0.1% Tween 20] for 1 h at room temperature and probed with primary antibodies overnight at 4 °C. Blots were washed with TBS-T and exposed to HRP conjugated goat-anti-mouse or goat-anti-rabbit secondary antibodies for 1 h at room temperature. Immunoreactive bands were detected by using ECL Plus reagents (GE Healthcare, Piscataway, NJ, USA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Colony Forming Unit Assay</h3><div class="NLM_p last">Freshly harvested mouse bone marrow cells or patient splenocytes (5 × 10<sup>4</sup> cells/mL) were assayed for colony forming units (CFUs) in 0.9% methylcellulose IMDM containing 30% FBS, glutamine (10<sup>–4</sup> M), β-mercaptoethanol (3.3 × 10<sup>–5</sup> M), GM-CSF (1.0 ng/mL), and varying doses of cryptotanshinone or the same concentrations of DMSO. After 7 days (mouse bone marrow cells) or 14 days (patient cells) of culture at 37 °C in a humidified 5% CO<sub>2</sub> incubator, myeloid colonies (CFU-GM and CFU-M) were counted under an inverted microscope.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Statistical Analysis</h3><div class="NLM_p last">Data are presented as the mean ± SEM. Statistical significance was determined using unpaired two-tailed Student’s <i>t</i> test. <i>p</i> < 0.05 was considered to be significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/jm400474r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figures S1–S7. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400474r/suppl_file/jm400474r_si_001.pdf">jm400474r_si_001.pdf (477.52 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400474r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Kui Qu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Hematology and Oncology,
Case Comprehensive Cancer Center, Case Western
Reserve University, 10900
Euclid Avenue, Cleveland, Ohio 44106, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#27445f5611674446544209424352"><span class="__cf_email__" data-cfemail="ff9c878ec9bf9c9e8c9ad19a9b8a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Hematology and Oncology,
Case Comprehensive Cancer Center, Case Western
Reserve University, 10900
Euclid Avenue, Cleveland, Ohio 44106, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China</span>; 
    <span class="hlFld-Affiliation affiliation">School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Yu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Hematology and Oncology,
Case Comprehensive Cancer Center, Case Western
Reserve University, 10900
Euclid Avenue, Cleveland, Ohio 44106, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Xu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Hematology and Oncology,
Case Comprehensive Cancer Center, Case Western
Reserve University, 10900
Euclid Avenue, Cleveland, Ohio 44106, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Ren Xu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Hematology and Oncology,
Case Comprehensive Cancer Center, Case Western
Reserve University, 10900
Euclid Avenue, Cleveland, Ohio 44106, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mignon L. Loh</span> - <span class="hlFld-Affiliation affiliation">Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California, San Francisco, San Francisco, California 94122, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Da Tang</span> - <span class="hlFld-Affiliation affiliation">Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>W.L., B.Y., and G.X. contributed equally to this paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d204e918-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institutes of Health Grants HD070716 and HL068212 (to C.-K.Q.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">SHP2</td><td class="NLM_def"><p class="first last">Src homology 2 domain-containing tyrosine phosphatase 2</p></td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">pY</td><td class="NLM_def"><p class="first last">phosphotyrosine</p></td></tr><tr><td class="NLM_term">JMML</td><td class="NLM_def"><p class="first last">juvenile myelomonocytic leukemia</p></td></tr><tr><td class="NLM_term">CADD</td><td class="NLM_def"><p class="first last">computer-aided drug design</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtiss, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-2331&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0lg3kGSxS4CB1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonzo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1831</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-1834&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchi&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masera, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-313&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0lgHOChlzVaHHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lgHOChlzVaHHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahlen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lg-iL-faH-CuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0lg-iL-faH-CuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lg-iL-faH-CuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flotho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliegauf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archambeault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullighan, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstraesser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueso-Ramos, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Heuvel-Eibrink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span> </span><span class="NLM_article-title">Mutations in CBL occur frequently in juvenile myelomonocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1859-1863&author=M.+L.+Lohauthor=D.+S.+Sakaiauthor=C.+Flothoauthor=M.+Kangauthor=M.+Fliegaufauthor=S.+Archambeaultauthor=C.+G.+Mullighanauthor=L.+Chenauthor=E.+Bergstraesserauthor=C.+E.+Bueso-Ramosauthor=P.+D.+Emanuelauthor=H.+Hasleauthor=J.+P.+Issaauthor=M.+M.+van+den+Heuvel-Eibrinkauthor=F.+Locatelliauthor=J.+Staryauthor=M.+Treboauthor=M.+Wlodarskiauthor=M.+Zeccaauthor=K.+M.+Shannonauthor=C.+M.+Niemeyer&title=Mutations+in+CBL+occur+frequently+in+juvenile+myelomonocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DSakai%26aufirst%3DD.%2BS.%26aulast%3DFlotho%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DFliegauf%26aufirst%3DM.%26aulast%3DArchambeault%26aufirst%3DS.%26aulast%3DMullighan%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBergstraesser%26aufirst%3DE.%26aulast%3DBueso-Ramos%26aufirst%3DC.%2BE.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DIssa%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bden%2BHeuvel-Eibrink%26aufirst%3DM.%2BM.%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DStary%26aufirst%3DJ.%26aulast%3DTrebo%26aufirst%3DM.%26aulast%3DWlodarski%26aufirst%3DM.%26aulast%3DZecca%26aufirst%3DM.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26atitle%3DMutations%2520in%2520CBL%2520occur%2520frequently%2520in%2520juvenile%2520myelomonocytic%2520leukemia%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1859%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Muramatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankowska, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzolli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciejewski, J. P.</span><span> </span><span class="NLM_article-title">Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=1969-1975&author=H.+Muramatsuauthor=H.+Makishimaauthor=A.+M.+Jankowskaauthor=H.+Cazzolliauthor=C.+O%E2%80%99Keefeauthor=N.+Yoshidaauthor=Y.+Xuauthor=N.+Nishioauthor=A.+Hamaauthor=H.+Yagasakiauthor=Y.+Takahashiauthor=K.+Katoauthor=A.+Manabeauthor=S.+Kojimaauthor=J.+P.+Maciejewski&title=Mutations+of+an+E3+ubiquitin+ligase+c-Cbl+but+not+TET2+mutations+are+pathogenic+in+juvenile+myelomonocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuramatsu%26aufirst%3DH.%26aulast%3DMakishima%26aufirst%3DH.%26aulast%3DJankowska%26aufirst%3DA.%2BM.%26aulast%3DCazzolli%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DNishio%26aufirst%3DN.%26aulast%3DHama%26aufirst%3DA.%26aulast%3DYagasaki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DManabe%26aufirst%3DA.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DMaciejewski%26aufirst%3DJ.%2BP.%26atitle%3DMutations%2520of%2520an%2520E3%2520ubiquitin%2520ligase%2520c-Cbl%2520but%2520not%2520TET2%2520mutations%2520are%2520pathogenic%2520in%2520juvenile%2520myelomonocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D1969%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismat, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fnm1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15273746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=849-857&author=T.+Arakiauthor=M.+G.+Mohiauthor=F.+A.+Ismatauthor=R.+T.+Bronsonauthor=I.+R.+Williamsauthor=J.+L.+Kutokauthor=W.+Yangauthor=L.+I.+Paoauthor=D.+G.+Gillilandauthor=J.+A.+Epsteinauthor=B.+G.+Neel&title=Mouse+model+of+Noonan+syndrome+reveals+cell+type-+and+gene+dosage-dependent+effects+of+Ptpn11+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span></div><div class="casAuthors">Araki, Toshiyuki; Mohi, M. Golam; Ismat, Fraz A.; Bronson, Roderick T.; Williams, Ifor R.; Kutok, Jeffery L.; Yang, Wentian; Pao, Lily I.; Gilliland, D. Gary; Epstein, Jonathan A.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-857</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Noonan syndrome is a common human autosomal dominant birth defect, characterized by short stature, facial abnormalities, heart defects and possibly increased risk of leukemia.  Mutations of Ptpn11 (also known as Shp2), which encodes the protein-tyrosine phosphatase Shp2, occur in ∼50% of individuals with Noonan syndrome, but their mol., cellular and developmental effects, and the relationship between Noonan syndrome and leukemia, are unclear.  We generated mice expressing the Noonan syndrome-assocd. mutant D61G.  When homozygous, the D61G mutant is embryonic lethal, whereas heterozygotes have decreased viability.  Surviving Ptpn11D61G/+ embryos (∼50%) have short stature, craniofacial abnormalities similar to those in Noonan syndrome, and myeloproliferative disease.  Severely affected Ptpn11D61G/+ embryos (∼50%) have multiple cardiac defects similar to those in mice lacking the Ras-GAP protein neurofibromin.  Their endocardial cushions have increased Erk activation, but Erk hyperactivation is cell and pathway specific.  Our results clarify the relationship between Noonan syndrome and leukemia and show that a single Ptpn11 gain-of-function mutation evokes all major features of Noonan syndrome by acting on multiple developmental lineages in a gene dosage-dependent and pathway-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmxo_WGTel7Vg90H21EOLACvtfcHk0lg2nSDF6zfvKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D&md5=69aae2a9730455356988fa32e7652c00</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnm1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1084%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DIsmat%26aufirst%3DF.%2BA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DEpstein%26aufirst%3DJ.%2BA.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMouse%2520model%2520of%2520Noonan%2520syndrome%2520reveals%2520cell%2520type-%2520and%2520gene%2520dosage-dependent%2520effects%2520of%2520Ptpn11%2520mutation%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2008-10-182626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=19179468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4414-4424&author=G.+Chanauthor=D.+Kalaitzidisauthor=T.+Usenkoauthor=J.+L.+Kutokauthor=W.+Yangauthor=M.+G.+Mohiauthor=B.+G.+Neel&title=Leukemogenic+Ptpn11+causes+fatal+myeloproliferative+disorder+via+cell-autonomous+effects+on+multiple+stages+of+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Usenko, Tatiana; Kutok, Jeffery L.; Yang, Wentian; Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4414-4424</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11, which encodes the tyrosine phosphatase SHP2, is mutated in approx. 35% of patients with juvenile myelomonocytic leukemia (JMML) and at a lower incidence in other neoplasms.  To model JMML pathogenesis, the authors generated knock-in mice that conditionally express the leukemia-assocd. mutant Ptpn11D61Y.  Expression of Ptpn11D61Y in all hematopoietic cells evokes a fatal myeloproliferative disorder (MPD), featuring leukocytosis, anemia, hepatosplenomegaly, and factor-independent colony formation by bone marrow (BM) and spleen cells.  The Lin-Sca1+cKit+ (LSK) compartment is expanded and "right-shifted," accompanied by increased stem cell factor (SCF)-evoked colony formation and Erk and Akt activation.  However, repopulating activity is decreased in diseased mice, and mice that do engraft with Ptpn11D61Y stem cells fail to develop MPD.  Ptpn11D61Y common myeloid progenitors (CMPs) and granulocyte-monocyte progenitors (GMPs) produce cytokine-independent colonies in a cell-autonomous manner and demonstrate elevated Erk and Stat5 activation in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation.  Ptpn11D61Y megakaryocyte-erythrocyte progenitors (MEPs) yield increased nos. of erythrocyte burst-forming units (BFU-Es), but MEPs and erythrocyte-committed progenitors (EPs) produce fewer erythrocyte colony-forming units (CFU-Es), indicating defective erythroid differentiation.  These studies provide a mouse model for Ptpn11-evoked MPD and show that this disease results from cell-autonomous and distinct lineage-specific effects of mutant Ptpn11 on multiple stages of hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cIq_57M9vrVg90H21EOLACvtfcHk0li7HRWvJft6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D&md5=e5363cc8f6acc1716ae263e5fb6c4585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-10-182626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-10-182626%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DUsenko%26aufirst%3DT.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DLeukemogenic%2520Ptpn11%2520causes%2520fatal%2520myeloproliferative%2520disorder%2520via%2520cell-autonomous%2520effects%2520on%2520multiple%2520stages%2520of%2520hematopoiesis%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D4414%26epage%3D4424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">1977</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=1977-1988&author=D.+Xuauthor=X.+Liuauthor=W.+M.+Yuauthor=H.+J.+Meyersonauthor=C.+Guoauthor=S.+L.+Gersonauthor=C.+K.+Qu&title=Non-lineage%2Fstage-restricted+effects+of+a+gain-of-function+mutation+in+tyrosine+phosphatase+Ptpn11+%28Shp2%29+on+malignant+transformation+of+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DMeyerson%26aufirst%3DH.%2BJ.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DNon-lineage%252Fstage-restricted%2520effects%2520of%2520a%2520gain-of-function%2520mutation%2520in%2520tyrosine%2520phosphatase%2520Ptpn11%2520%2528Shp2%2529%2520on%2520malignant%2520transformation%2520of%2520hematopoietic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D1977%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0li7HRWvJft6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2F379277a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=8538796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=277-280&author=M.+J.+Eckauthor=S.+Pluskeyauthor=T.+Trubauthor=S.+C.+Harrisonauthor=S.+E.+Shoelson&title=Spatial+constraints+on+the+recognition+of+phosphoproteins+by+the+tandem+SH2+domains+of+the+phosphatase+SH-PTP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span></div><div class="casAuthors">Eck, Michael J.; Pluskey, Scott; Trub, Thomas; Harrison, Stephen C.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6562</span>),
    <span class="NLM_cas:pages">277-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The domain organization of many signaling proteins facilitates a segregation of binding, catalytic and regulatory functions.  The mammalian SH2 domain protein tyrosine phosphatases (PTPs) contain tandem SH2 domains and a single carboxy-terminal catalytic domain.  SH-PTP1 (PTP1C, HCP) and SH-PTP2 (Syp, PTP2C, PTP1D) function downstream from tyrosine kinase-linked insulin, growth factor, cytokine and antigen receptors.  As well as directing subcellular localization by binding to receptors and their substrates, the two SH2 domains of these PTPs function together to regulate catalysis.  Here the authors report the structure of the tandem SH2 domains of SH-PTP2 in complex with monophosphopeptides.  A fixed relative orientation of the two domains, stabilized by a disulfide bond and a small hydrophobic patch within the interface, separates the peptide binding sites by ∼ 40 Å.  The defined orientation of the SH2 domains in the structure, and data showing that peptide orientation and spacing between binding sites is crit. for enzymic activation, suggest that spatial constraints are important in this multidomain protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojp1hm-r1vcbVg90H21EOLACvtfcHk0li7HRWvJft6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D&md5=c4d7380b9e9f320a09cbec59a93673b8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F379277a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379277a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DT.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DSpatial%2520constraints%2520on%2520the%2520recognition%2520of%2520phosphoproteins%2520by%2520the%2520tandem%2520SH2%2520domains%2520of%2520the%2520phosphatase%2520SH-PTP2%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0ljcguVK_MvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30984</span><span class="NLM_x">–</span> <span class="NLM_lpage">30993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-30993&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+McGregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0ljcguVK_MvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcGregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D30993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases in the JAK/STAT pathway</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4925</span><span class="NLM_x">–</span> <span class="NLM_lpage">4932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.2741%2F3051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18508557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=4925-4932&author=D.+Xuauthor=C.+K.+Qu&title=Protein+tyrosine+phosphatases+in+the+JAK%2FSTAT+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases in the JAK/STAT pathway</span></div><div class="casAuthors">Xu, Dan; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4925-4932</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in controlling cellular activities in response to extracellular cytokines.  Dysfunctions of the JAK/STAT pathway result in various hematopoietic and immune disorders.  The central events in regulating this pathway are tyrosine phosphorylation and dephosphorylation of the signaling components, which are carried out by protein tyrosine kinases and protein tyrosine phosphatases (PTP), resp.  Here, we review recent advances in the regulatory roles of PTPs, in particular, SHP2 phosphatase, in the JAK/STAT signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1iYtqQyD_7Vg90H21EOLACvtfcHk0ljcguVK_MvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D&md5=d3f84b6306220659ef34e4bf43cab87e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2741%2F3051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3051%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%2520in%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D4925%26epage%3D4932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljcguVK_MvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0lhALosu2g9H_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The “Shp”ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%9CShp%E2%80%9Ding+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%259CShp%25E2%2580%259Ding%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">The molecular functions of Shp2 in the Ras/mitogen-activated protein kinase (ERK1/2) pathway</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2Fj.cellsig.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17993263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=453-459&author=M.+Danceauthor=A.+Montagnerauthor=J.+P.+Sallesauthor=A.+Yartauthor=P.+Raynal&title=The+molecular+functions+of+Shp2+in+the+Ras%2Fmitogen-activated+protein+kinase+%28ERK1%2F2%29+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span></div><div class="casAuthors">Dance, Marie; Montagner, Alexandra; Salles, Jean-Pierre; Yart, Armelle; Raynal, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-459</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Shp2 is a ubiquitous tyrosine phosphatase contg. Src Homol. 2 domains which plays major biol. functions in response to various growth factors, hormones or cytokines.  This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway.  Recent progresses have been made in the understanding of the mol. mechanisms involved in this regulation.  We review here, and discuss the physiol. relevance, of the following mol. functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, neg. regulator of Sprouty, neg. regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2Kpmuyw1urVg90H21EOLACvtfcHk0lhALosu2g9H_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D&md5=a512a7f588e669c4ea4bb8fcc3d872db</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDance%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520functions%2520of%2520Shp2%2520in%2520the%2520Ras%252Fmitogen-activated%2520protein%2520kinase%2520%2528ERK1%252F2%2529%2520pathway%26jtitle%3DCell.%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Newman, D. J.</span><span> </span><span class="NLM_article-title">Natural products as leads to potential drugs: an old process or the new hope for drug discovery?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2589-2599&author=D.+J.+Newman&title=Natural+products+as+leads+to+potential+drugs%3A+an+old+process+or+the+new+hope+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0704090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704090%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%2520as%2520leads%2520to%2520potential%2520drugs%253A%2520an%2520old%2520process%2520or%2520the%2520new%2520hope%2520for%2520drug%2520discovery%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2589%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocchinfuso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palleschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucci, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1086%2F499925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=16358218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=279-290&author=M.+Tartagliaauthor=S.+Martinelliauthor=L.+Stellaauthor=G.+Bocchinfusoauthor=E.+Flexauthor=V.+Cordedduauthor=G.+Zampinoauthor=I.+Burgtauthor=A.+Palleschiauthor=T.+C.+Petrucciauthor=M.+Sorciniauthor=C.+Schochauthor=R.+Foaauthor=P.+D.+Emanuelauthor=B.+D.+Gelb&title=Diversity+and+functional+consequences+of+germline+and+somatic+PTPN11+mutations+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Stella, Lorenzo; Bocchinfuso, Gianfranco; Flex, Elisabetta; Cordeddu, Viviana; Zampino, Giuseppe; van der Burgt, Ineke; Palleschi, Antonio; Petrucci, Tamara C.; Sorcini, Mariella; Schoch, Claudia; Foa, Robin; Emanuel, Peter D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Germline mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome (NS) and the clin. related LEOPARD syndrome (LS), whereas somatic mutations in the same gene contribute to leukemogenesis.  On the basis of our previously gathered genetic and biochem. data, we proposed a model that splits NS- and leukemia-assocd. PTPN11 mutations into two major classes of activating lesions with differential perturbing effects on development and hematopoiesis.  To test this model, we investigated further the diversity of germline and somatic PTPN11 mutations, delineated the assocn. of those mutations with disease, characterized biochem. a panel of mutant SHP-2 proteins recurring in NS, LS, and leukemia, and performed mol. dynamics simulations to det. the structural effects of selected mutations.  Our results document a strict correlation between the identity of the lesion and disease and demonstrate that NS-causative mutations have less potency for promoting SHP-2 gain of function than do leukemia-assocd. ones.  Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxEltZHtDmELVg90H21EOLACvtfcHk0ljKJcyprWbwtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlGrtQ%253D%253D&md5=0831d0f9177ca5d3a5e20a4cf5bfe36c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1086%2F499925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F499925%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DStella%26aufirst%3DL.%26aulast%3DBocchinfuso%26aufirst%3DG.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBurgt%26aufirst%3DI.%26aulast%3DPalleschi%26aufirst%3DA.%26aulast%3DPetrucci%26aufirst%3DT.%2BC.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DSchoch%26aufirst%3DC.%26aulast%3DFoa%26aufirst%3DR.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DDiversity%2520and%2520functional%2520consequences%2520of%2520germline%2520and%2520somatic%2520PTPN11%2520mutations%2520in%2520human%2520disease%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2006%26volume%3D78%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawley, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">6004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5995-6004&author=W.+M.+Yuauthor=T.+S.+Hawleyauthor=R.+G.+Hawleyauthor=C.+K.+Qu&title=Catalytic-dependent+and+-independent+roles+of+SHP-2+tyrosine+phosphatase+in+interleukin-3+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DHawley%26aufirst%3DT.%2BS.%26aulast%3DHawley%26aufirst%3DR.%2BG.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DCatalytic-dependent%2520and%2520-independent%2520roles%2520of%2520SHP-2%2520tyrosine%2520phosphatase%2520in%2520interleukin-3%2520signaling%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D5995%26epage%3D6004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castleberry, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuckerman, K. S.</span><span> </span><span class="NLM_article-title">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=1704804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=925-929&author=P.+D.+Emanuelauthor=L.+J.+Batesauthor=R.+P.+Castleberryauthor=R.+J.+Gualtieriauthor=K.+S.+Zuckerman&title=Selective+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor+by+juvenile+chronic+myeloid+leukemia+hematopoietic+progenitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span></div><div class="casAuthors">Emanuel P D; Bates L J; Castleberry R P; Gualtieri R J; Zuckerman K S</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-9</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Juvenile chronic myelogenous leukemia (JCML) is a good model for the study of myeloproliferation because JCML hematopoietic progenitor cells grow in vitro at very low cell densities without the addition of exogenous stimulus.  Previous studies have demonstrated that this proliferation is dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF), and that removal of monocytes from the cell population before culture eliminates this "spontaneous" myeloproliferation, suggesting a paracrine role of monocyte stimulation.  However, subsequent studies have shown that increased GM-CSF production from the JCML monocytes is not a consistent finding and therefore not a plausible sole mechanism.  In examining hematopoietic growth factor dose-response curves, both JCML GM and erythroid nonadherent progenitor cell populations displayed a marked and selective hypersensitivity to GM-CSF.  Responses to interleukin-3 and G-CSF were identical to control dose-response curves.  This is the first demonstration of a myeloid leukemia in which hypersensitivity to a specific growth factor appears to be involved in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqJDPh116g5F1C8OJBvdfbfW6udTcc2ea3oNXjg4Naprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D&md5=380f655a2c503367555ebf1d922e3697</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DBates%26aufirst%3DL.%2BJ.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DGualtieri%26aufirst%3DR.%2BJ.%26aulast%3DZuckerman%26aufirst%3DK.%2BS.%26atitle%3DSelective%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520by%2520juvenile%2520chronic%2520myeloid%2520leukemia%2520hematopoietic%2520progenitors%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26spage%3D925%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lyubynska, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauchle, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akutagawa, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, B. S.</span><span> </span><span class="NLM_article-title">A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">76ra27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1126%2Fscitranslmed.3001069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=76ra27&author=N.+Lyubynskaauthor=M.+F.+Gormanauthor=J.+O.+Lauchleauthor=W.+X.+Hongauthor=J.+K.+Akutagawaauthor=K.+Shannonauthor=B.+S.+Braun&title=A+MEK+inhibitor+abrogates+myeloproliferative+disease+in+Kras+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001069%26sid%3Dliteratum%253Aachs%26aulast%3DLyubynska%26aufirst%3DN.%26aulast%3DGorman%26aufirst%3DM.%2BF.%26aulast%3DLauchle%26aufirst%3DJ.%2BO.%26aulast%3DHong%26aufirst%3DW.%2BX.%26aulast%3DAkutagawa%26aufirst%3DJ.%2BK.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DBraun%26aufirst%3DB.%2BS.%26atitle%3DA%2520MEK%2520inhibitor%2520abrogates%2520myeloproliferative%2520disease%2520in%2520Kras%2520mutant%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D76ra27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munugalavadla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorhorst, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span> </span><span class="NLM_article-title">Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3737</span><span class="NLM_x">–</span> <span class="NLM_lpage">3742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2004-10-4002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15644411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFejtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3737-3742&author=R.+J.+Chanauthor=M.+B.+Leedyauthor=V.+Munugalavadlaauthor=C.+S.+Voorhorstauthor=Y.+Liauthor=M.+Yuauthor=R.+Kapur&title=Human+somatic+PTPN11+mutations+induce+hematopoietic-cell+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor</span></div><div class="casAuthors">Chan, Rebecca J.; Leedy, Melissa B.; Munugalavadla, Veerendra; Voorhorst, Cara S.; Li, Yanjun; Yu, Menggang; Kapur, Reuben</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3737-3742</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Juvenile myelomonocytic leukemia (JMML) is a lethal disease of young children characterized by hypersensitivity of hematopoietic progenitors to granulocyte-macrophage colony-stimulating factor (GM-CSF).  Mutations in PTPN11, which encodes the protein tyrosine phosphatase Shp-2, are common in JMML.  We hypothesized that PTPN11 mutations induce hypersensitivity of hematopoietic progenitors to GM-CSF and confer increased GM-CSF-stimulated phospho-extracellular signal-regulated kinase (Erk) levels.  To test this hypothesis, the wild-type (WT) and 3 mutant Ptpn11 cDNAs (E76K, D61V, and D61Y) were transduced into murine bone marrow cells to examine GM-CSF-stimulated granulocyte-macrophage colony-forming unit (CFU-GM) growth, macrophage progenitor proliferation, and activation of the Ras signaling pathway.  Expression of the Shp-2 mutants induced progenitor cell hypersensitivity to GM-CSF compared with cells transduced with vector alone or WT Shp-2.  Macrophage progenitors expressing the Shp-2 mutants displayed both basal and GM-CSF-stimulated hyperproliferation compared with cells transduced with vector alone or WT Shp-2.  Consistently, macrophage progenitors transduced with the Shp-2 mutants demonstrated constitutively elevated phospho-Erk levels and sustained activation of phospho-Erk following GM-CSF stimulation compared with vector alone or WT Shp-2.  These data support the hypothesis that PTPN11 mutations induce hematopoietic progenitor hypersensitivity to GM-CSF due to hyperactivation of the Ras signaling axis and provide a basis for the GM-CSF signaling pathway as a target for rational drug design in JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzelkPWl227Vg90H21EOLACvtfcHk0ljZXaWboBFKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFejtLY%253D&md5=3120af906beb1ae08c2b6717a6030235</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-4002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-4002%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DLeedy%26aufirst%3DM.%2BB.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DVoorhorst%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DKapur%26aufirst%3DR.%26atitle%3DHuman%2520somatic%2520PTPN11%2520mutations%2520induce%2520hematopoietic-cell%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D3737%26epage%3D3742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nishida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1111%2Fj.1349-7006.2003.tb01396.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14662016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=1029-1033&author=K.+Nishidaauthor=T.+Hirano&title=The+role+of+Gab+family+scaffolding+adapter+proteins+in+the+signal+transduction+of+cytokine+and+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors</span></div><div class="casAuthors">Nishida, Keigo; Hirano, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  The Grb2-assocd. binder (Gab) family adapter proteins are scaffolding adapter mols. that display sequence similarity with Drosophila DOS (daughter of sevenless), which is a substrate for the protein tyrosine phosphatase Corkscrew.  Gab proteins contain a pleckstrin homol. (PH) domain and binding sites for SH2 and SH3 domains.  A no. of studies in multiple systems have implicated Gab in signaling via many different types of receptors, such as growth factor, cytokine, and antigen receptors, and via oncoproteins.  Recent studies of Gab1 and Gab2 knockout mice have clearly indicated an important role for Gabs in vivo.  Gab1-deficient mice die as embryos with multiple defects in placental, heart, skin, and muscle development.  Gab2-deficient mice are viable, but have a defect in the mast cell lineages and in allergic reactions.  Given the apparently central role played by Gab signaling via many receptors, delineating the precise mechanism(s) of Gab-mediated signaling is crit. to understanding how cytokines, growth factors, and oncoproteins mediate a variety of biol. activities: cell growth, differentiation, survival, and malignant transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvmpShz2VJB7Vg90H21EOLACvtfcHk0ljZXaWboBFKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSrtbk%253D&md5=00acec1b8b62f2a59fb671d6782452e2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01396.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01396.x%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DK.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520Gab%2520family%2520scaffolding%2520adapter%2520proteins%2520in%2520the%2520signal%2520transduction%2520of%2520cytokine%2520and%2520growth%2520factor%2520receptors%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The “Gab” in signal transduction</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0962-8924%2803%2900002-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12628344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1WqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=122-130&author=H.+Guauthor=B.+G.+Neel&title=The+%E2%80%9CGab%E2%80%9D+in+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Gab in signal transduction</span></div><div class="casAuthors">Gu, Haihua; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-130</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosine phosphorylation plays an important role in controlling cellular growth, differentiation, and function.  Abnormal regulation of tyrosine phosphorylation can result in human diseases such as cancer.  A major challenge of signal transduction research is to det. how the initial activation of protein-tyrosine kinases (PTKs) by extracellular stimuli triggers multiple downstream signaling cascades, which ultimately elicit diverse cellular responses.  Recent studies reveal that members of the Gab/Dos subfamily of scaffolding adaptor proteins (hereafter, Gab proteins) play a crucial role in transmitting key signals that control cell growth, differentiation, and function from multiple receptors.  Here, we review the structure, mechanism of action, and function of these interesting mols. in normal biol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtujtVbSiEF7Vg90H21EOLACvtfcHk0ljZXaWboBFKDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1WqsLg%253D&md5=f8ada7e6a7fcf42c857b9b503a4fc7fa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900002-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900002-3%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520%25E2%2580%259CGab%25E2%2580%259D%2520in%2520signal%2520transduction%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D122%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapp, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2004-11-4207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15761018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=311-317&author=S.+Schubbertauthor=K.+Lieuwauthor=S.+L.+Roweauthor=C.+M.+Leeauthor=X.+Liauthor=M.+L.+Lohauthor=D.+W.+Clappauthor=K.+M.+Shannon&title=Functional+analysis+of+leukemia-associated+PTPN11+mutations+in+primary+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells</span></div><div class="casAuthors">Schubbert, Suzanne; Lieuw, Kenneth; Rowe, Sara L.; Lee, Connie M.; Li, XiaXin; Loh, Mignon L.; Clapp, D. Wade; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11 encodes the protein tyrosine phosphatase SHP-2, which relays signals from growth factor receptors to Ras and other effectors.  Germline PTPN11 mutations underlie about 50% of Noonan syndrome (NS), a developmental disorder that is assocd. with an elevated risk of juvenile myelomonocytic leukemia (JMML).  Somatic PTPN11 mutations were recently identified in about 35% of patients with JMML; these mutations introduce amino acid substitutions that are largely distinct from those found in NS.  We assessed the functional consequences of leukemia-assocd. PTPN11 mutations in murine hematopoietic cells.  Expressing an E76K SHP-2 protein induced a hypersensitive pattern of granulocyte-macrophage colony-forming unit (CFU-GM) colony growth in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) that was dependent on SHP-2 catalytic activity.  E76K SHP-2 expression also enhanced the growth of immature progenitor cells with high replating potential, perturbed erythroid growth, and impaired normal differentiation in liq. cultures.  In addn., leukemia-assocd. SHP-2 mutations conferred a stronger phenotype than a germline mutation found in patients with NS.  Mutant SHP-2 proteins induce aberrant growth in multiple hematopoietic compartments, which supports a primary role of hyperactive Ras in the pathogenesis of JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodGp2TL7I53LVg90H21EOLACvtfcHk0lih1ZrQ8YjuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWjtrk%253D&md5=bb0309533d245fd69d069a8b69e67a35</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-11-4207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-11-4207%26sid%3Dliteratum%253Aachs%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DLieuw%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DFunctional%2520analysis%2520of%2520leukemia-associated%2520PTPN11%2520mutations%2520in%2520primary%2520hematopoietic%2520cells%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">5426</span><span class="NLM_x">–</span> <span class="NLM_lpage">5434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=5426-5434&author=W.+M.+Yuauthor=H.+Dainoauthor=J.+Chenauthor=K.+D.+Buntingauthor=C.+K.+Qu&title=Effects+of+a+leukemia-associated+gain-of-function+mutation+of+SHP-2+phosphatase+on+interleukin-3+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DDaino%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBunting%26aufirst%3DK.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DEffects%2520of%2520a%2520leukemia-associated%2520gain-of-function%2520mutation%2520of%2520SHP-2%2520phosphatase%2520on%2520interleukin-3%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D5426%26epage%3D5434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhou, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, M. S. S.</span><span> </span><span class="NLM_article-title">Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1177%2F0091270005282630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=16291709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1345-1359&author=L.+M.+Zhouauthor=Z.+Zuoauthor=M.+S.+S.+Chow&title=Danshen%3A+an+overview+of+its+chemistry%2C+pharmacology%2C+pharmacokinetics%2C+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use</span></div><div class="casAuthors">Zhou, Limin; Zuo, Zhong; Chow, Moses Sing Sum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1345-1359</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Danshen, the dried root of Salvia miltiorrhiza, has been widely used in China and, to a lesser extent, in Japan, the United States, and other European countries for the treatment of cardiovascular and cerebrovascular diseases.  In China, the specific clin. use is angina pectoris, hyperlipidemia, and acute ischemic stroke.  The current review covers its traditional uses, chem. constituents, pharmacol. activities, pharmacokinetics, clin. applications, and potential herb-drug interactions based on information obtained in both the English and Chinese literature.  Although numerous clin. trials have demonstrated that certain Danshen products in China are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality.  Therefore, large randomized clin. trials and further scientific research to det. its mechanism of actions will be necessary to ensure the safety, effectiveness, and better understanding of its action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSr_sWcH9VsbVg90H21EOLACvtfcHk0lih1ZrQ8YjuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjtrzL&md5=b2475589ba03dab9465808f6756dbce7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0091270005282630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270005282630%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%2BM.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DChow%26aufirst%3DM.%2BS.%2BS.%26atitle%3DDanshen%253A%2520an%2520overview%2520of%2520its%2520chemistry%252C%2520pharmacology%252C%2520pharmacokinetics%252C%2520and%2520clinical%2520use%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D45%26spage%3D1345%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foo, L. Y.</span><span> </span><span class="NLM_article-title">Polyphenolics of <i>Salvia</i>—a review</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=117-140&author=Y.+Luauthor=L.+Y.+Foo&title=Polyphenolics+of+Salvia%E2%80%94a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DFoo%26aufirst%3DL.%2BY.%26atitle%3DPolyphenolics%2520of%2520Salvia%25E2%2580%2594a%2520review%26jtitle%3DPhytochemistry%26date%3D2002%26volume%3D59%26spage%3D117%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Stickel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krahmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuppan, D.</span><span> </span><span class="NLM_article-title">Antifibrotic properties of botanicals in chronic liver disease</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12143213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=1102-1108&author=F.+Stickelauthor=B.+Brinkhausauthor=N.+Krahmerauthor=H.+K.+Seitzauthor=E.+G.+Hahnauthor=D.+Schuppan&title=Antifibrotic+properties+of+botanicals+in+chronic+liver+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antifibrotic properties of botanicals in chronic liver disease</span></div><div class="casAuthors">Stickel, F.; Brinkhaus, B.; Kraehmer, N.; Seitz, H. K.; Hahn, E. G.; Schuppan, D.</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-Gastroenterology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">1102-1108</span>CODEN:
                <span class="NLM_cas:coden">HEGAD4</span>;
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    
            (<span class="NLM_cas:orgname">H.G.E. Update Medical Publishing</span>)
        </div><div class="casAbstract">A review.  Cirrhosis of the liver is a major complication of various chronic liver diseases and results from excess prodn. and decreased degrdn. of extracellular matrix.  Proinflammatory cytokines, toxic metabolites and certain drugs can trigger enhanced fibrogenesis in hepatic stellate cells and myofibroblasts, the major matrix-producing cells.  Since treatment of established cirrhosis is limited, therapeutic interventions that inhibit or mitigate fibrogenesis are needed.  Numerous drugs have been investigated for their antifibrotic potential and botanicals constitute a significant fraction of them.  Colchicine has been used to treat various chronic liver diseases with controversial results.  To date, there is a lack of studies in appropriate animal models and well-controlled human trials to demonstrate its antifibrotic properties.  Silymarin has so far failed to clearly show an antifibrotic effect in human studies, whereas animal expts. suggest that this mixt. of flavolignanes may be beneficial in patients which have not yet developed cirrhosis.  Animal studies indicate an antifibrotic potential of Shosaiko-to, a herbal combination frequently used in China and Japan for the treatment of chronic viral hepatitis, but mechanisms of action need to be further explored.  Other botanicals include trans-resveratrol, a flavonoid extd. from grapevine, and Salvia miltiorrhiza which were shown to interfere with the process of hepatic stellate cell activation.  Herbal combinations, such as compd. 861 and LIV.52 were advocated as antifibrotics or hepatoprotectives, but studies in humans have either been of questionable design or resulted in cessation of the trial due to adverse outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZF9BD30hxn7Vg90H21EOLACvtfcHk0lih1ZrQ8YjuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFOrurc%253D&md5=71d24dcb2fe5c21f2da189806abf6060</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStickel%26aufirst%3DF.%26aulast%3DBrinkhaus%26aufirst%3DB.%26aulast%3DKrahmer%26aufirst%3DN.%26aulast%3DSeitz%26aufirst%3DH.%2BK.%26aulast%3DHahn%26aufirst%3DE.%2BG.%26aulast%3DSchuppan%26aufirst%3DD.%26atitle%3DAntifibrotic%2520properties%2520of%2520botanicals%2520in%2520chronic%2520liver%2520disease%26jtitle%3DHepatogastroenterology%26date%3D2002%26volume%3D49%26spage%3D1102%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wojcikowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobe, G.</span><span> </span><span class="NLM_article-title">Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=160-166&author=K.+Wojcikowskiauthor=D.+W.+Johnsonauthor=G.+Gobe&title=Herbs+or+natural+substances+as+complementary+therapies+for+chronic+kidney+disease%3A+ideas+for+future+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWojcikowski%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BW.%26aulast%3DGobe%26aufirst%3DG.%26atitle%3DHerbs%2520or%2520natural%2520substances%2520as%2520complementary%2520therapies%2520for%2520chronic%2520kidney%2520disease%253A%2520ideas%2520for%2520future%2520studies%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2006%26volume%3D147%26spage%3D160%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowbay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. F.</span><span> </span><span class="NLM_article-title">Transport of cryptotanshinone, a major active triterpenoid in <i>Salvia miltiorrhiza</i> Bunge widely used in the treatment of stroke and Alzheimer’s disease, across the blood–brain barrier</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.2174%2F138920007780655441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17504224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=365-377&author=X.+Y.+Yuauthor=S.+G.+Linauthor=X.+Chenauthor=Z.+W.+Zhouauthor=J.+Liangauthor=W.+Duanauthor=B.+Chowbayauthor=J.+Y.+Wenauthor=E.+Chanauthor=J.+Caoauthor=C.+G.+Liauthor=S.+F.+Zhou&title=Transport+of+cryptotanshinone%2C+a+major+active+triterpenoid+in+Salvia+miltiorrhiza+Bunge+widely+used+in+the+treatment+of+stroke+and+Alzheimer%E2%80%99s+disease%2C+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier</span></div><div class="casAuthors">Yu, Xi-Yong; Lin, Shu-Guang; Chen, Xiao; Zhou, Zhi-Wei; Liang, Jun; Duan, Wei; Chowbay, Balram; Wen, Jing-Yuan; Chan, Eli; Cao, Jie; Li, Chun-Guang; Zhou, Shu-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cryptotanshinone (CTS), a major constituent from the roots of Salvia miltiorrhiza (Danshen), is widely used in the treatment of coronary heart disease, stroke, and less commonly Alzheimer's disease.  Our recent study indicates that CTS is a substrate for P-glycoprotein (PgP/MDR1/ABCB1).  This study has investigated the nature of the brain distribution of CTS across the brain-blood barrier (BBB) using several in vitro and in vivo rodent models.  A polarized transport of CTS was found in rat primary microvascular endothelial cell (RBMVEC) monolayers, with facilitated efflux from the abluminal side to luminal side.  Addn. of a PgP (e.g. verapamil and quinidine) or multi-drug resistance protein 1/2 (MRP1/2) inhibitor (e.g. probenecid and MK-571) in both luminal and abluminal sides attenuated the polarized transport.  In a bilateral in situ brain perfusion model, the uptake of CTS into the cerebrum increased from 0.52% at 1 min to 11.13 mL/100 g tissue at 30 min and was significantly greater than that of sucrose.  Co-perfusion of a PgP/MDR1 (e.g. verapamil) or MRP1/2 inhibitor (e.g. probenecid) significantly increased the brain distribution of CTS by 35.1-163.6%.  The brain levels of CTS were only about 21% of those in blood plasma, and were significantly increased when coadministered with verapamil or probenecid in rats.  The brain levels of CTS in rats subjected to middle cerebral artery occlusion and rats treated with quinolinic acid (a neurotoxin) were about 2- to 2.5-fold higher than the control rats.  Moreover, the brain levels in mdr1a(-/-) and mrp1(-/-) mice were 10.9- and 1.5-fold higher than those in the wild-type mice, resp.  Taken collectively, these findings indicate that PgP and Mrp1 limit the brain penetration of CTS in rodents, suggesting a possible role of PgP and MRP1 in limiting the brain penetration of CTS in patients and causing drug resistance to Danshen therapy and interactions with conventional drugs that are substrates of PgP and MRP1.  Further studies are needed to explore the role of other drug transporters in restricting the brain penetration of CTS and the clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZbDUCmJDuPLVg90H21EOLACvtfcHk0lgiNlpjfnRcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFehu7s%253D&md5=745d76a754cfea7c14b0a6d574ee0003</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F138920007780655441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780655441%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BY.%26aulast%3DLin%26aufirst%3DS.%2BG.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%2BW.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChowbay%26aufirst%3DB.%26aulast%3DWen%26aufirst%3DJ.%2BY.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%2BG.%26aulast%3DZhou%26aufirst%3DS.%2BF.%26atitle%3DTransport%2520of%2520cryptotanshinone%252C%2520a%2520major%2520active%2520triterpenoid%2520in%2520Salvia%2520miltiorrhiza%2520Bunge%2520widely%2520used%2520in%2520the%2520treatment%2520of%2520stroke%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D365%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Molecular evidence of cryptotanshinone for treatment and prevention of human cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=979-987&author=W.+Chenauthor=Y.+Luauthor=G.+Chenauthor=S.+Huang&title=Molecular+evidence+of+cryptotanshinone+for+treatment+and+prevention+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DMolecular%2520evidence%2520of%2520cryptotanshinone%2520for%2520treatment%2520and%2520prevention%2520of%2520human%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D979%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Shin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, B. M.</span><span> </span><span class="NLM_article-title">Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F0008-5472.CAN-08-2575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=19118003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=193-202&author=D.+S.+Shinauthor=H.+N.+Kimauthor=K.+D.+Shinauthor=Y.+J.+Yoonauthor=S.+J.+Kimauthor=D.+C.+Hanauthor=B.+M.+Kwon&title=Cryptotanshinone+inhibits+constitutive+signal+transducer+and+activator+of+transcription+3+function+through+blocking+the+dimerization+in+DU145+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells</span></div><div class="casAuthors">Shin, Dae-Seop; Kim, Hye-Nan; Shin, Ki Deok; Yoon, Young Ju; Kim, Seung-Jun; Han, Dong Cho; Kwon, Byoung-Mog</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-202</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Because signal transducer and activator of transcription 3 (STAT3) is constitutively activated in most human solid tumors and is involved in the proliferation, angiogenesis, immune evasion, and antiapoptosis of cancer cells, researchers have focused on STAT3 as a target for cancer therapy.  We screened for natural compds. that inhibit the activity of STAT3 using a dual-luciferase assay.  Cryptotanshinone was identified as a potent STAT3 inhibitor.  Cryptotanshinone rapidly inhibited STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells and the growth of the cells through 96 h of the treatment.  Inhibition of STAT3 Tyr705 phosphorylation in DU145 cells decreased the expression of STAT3 downstream target proteins such as cyclin D1, survivin, and Bcl-xL.  To investigate the cryptotanshinone inhibitory mechanism in DU145 cells, we analyzed proteins upstream of STAT3.  Although phosphorylation of Janus-activated kinase (JAK) 2 was inhibited by 7 μmol/L cryptotanshinone at 24 h, inhibition of STAT3 Tyr705 phosphorylation occurred within 30 min and the activity of the other proteins was not affected.  These results suggest that inhibition of STAT3 phosphorylation is caused by a JAK2-independent mechanism, with suppression of JAK2 phosphorylation as a secondary effect of cryptotanshinone treatment.  Continuing expts. revealed the possibility that cryptotanshinone might directly bind to STAT3 mols.  Cryptotanshinone was colocalized with STAT3 mols. in the cytoplasm and inhibited the formation of STAT3 dimers.  Computational modeling showed that cryptotanshinone could bind to the SH2 domain of STAT3.  These results suggest that cryptotanshinone is a potent anticancer agent targeting the activation STAT3 protein.  It is the first report that cryptotanshinone has antitumor activity through the inhibition of STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2CVvIW5pBbVg90H21EOLACvtfcHk0lgiNlpjfnRcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCm&md5=f318d248355d742ef874136ccdc9c053</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2575%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DShin%26aufirst%3DK.%2BD.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DHan%26aufirst%3DD.%2BC.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26atitle%3DCryptotanshinone%2520inhibits%2520constitutive%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520function%2520through%2520blocking%2520the%2520dimerization%2520in%2520DU145%2520prostate%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D193%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F1940-6207.CAPR-10-0020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GrtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1015-1025&author=W.+Chenauthor=Y.+Luoauthor=L.+Liuauthor=H.+Zhouauthor=B.+Xuauthor=X.+Hanauthor=T.+Shenauthor=Z.+Liuauthor=Y.+Luauthor=S.+Huang&title=Cryptotanshinone+inhibits+cancer+cell+proliferation+by+suppressing+mammalian+target+of+rapamycin-mediated+cyclin+D1+expression+and+Rb+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation</span></div><div class="casAuthors">Chen, Wenxing; Luo, Yan; Liu, Lei; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Liu, Zhijun; Lu, Yin; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1015-1025</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">Cryptotanshinone (CPT), a natural compd. isolated from the plant Salvia miltiorrhiza Bunge, is a potential anticancer agent.  However, little is known about its anticancer mechanism.  Here, we show that CPT inhibited cancer cell proliferation by arresting cells in G1-G0 phase of the cell cycle.  This is assocd. with the inhibition of cyclin D1 expression and retinoblastoma (Rb) protein phosphorylation.  Furthermore, we found that CPT inhibited the signaling pathway of the mammalian target of rapamycin (mTOR), a central regulator of cell proliferation.  This is evidenced by the findings that CPT inhibited type I insulin-like growth factor I- or 10% fetal bovine serum-stimulated phosphorylation of mTOR, p70 S6 kinase 1, and eukaryotic initiation factor 4E binding protein 1 in a concn.- and time-dependent manner.  Expression of constitutively active mTOR conferred resistance to CPT inhibition of cyclin D1 expression and Rb phosphorylation, as well as cell growth.  The results suggest that CPT is a novel anti-proliferative agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrnnLSnR0oLVg90H21EOLACvtfcHk0lg4_yVIW61tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GrtL3M&md5=bab2816a7bd03c86782446531f654b96</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-10-0020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-10-0020%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCryptotanshinone%2520inhibits%2520cancer%2520cell%2520proliferation%2520by%2520suppressing%2520mammalian%2520target%2520of%2520rapamycin-mediated%2520cyclin%2520D1%2520expression%2520and%2520Rb%2520phosphorylation%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2010%26volume%3D3%26spage%3D1015%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F1940-6207.CAPR-11-0551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2iu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=778-787&author=W.+Chenauthor=L.+Liuauthor=Y.+Luoauthor=Y.+Odakaauthor=S.+Awateauthor=H.+Zhouauthor=T.+Shenauthor=S.+Zhengauthor=Y.+Luauthor=S.+Huang&title=Cryptotanshinone+activates+p38%2FJNK+and+inhibits+Erk1%2F2+leading+to+caspase-independent+cell+death+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells</span></div><div class="casAuthors">Chen, Wenxing; Liu, Lei; Luo, Yan; Odaka, Yoshinobu; Awate, Sanket; Zhou, Hongyu; Shen, Tao; Zheng, Shizhong; Lu, Yin; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">778-787</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cryptotanshinone (CPT), a natural compd. isolated from the plant Salvia miltiorrhiza Bunge, is a potential anticancer agent.  However, the underlying mechanism is not well understood.  Here, we show that CPT induced caspase-independent cell death in human tumor cells (Rh30, DU145, and MCF-7).  Besides downregulating antiapoptotic protein expression of survivin and Mcl-1, CPT increased phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (INK), and inhibited phosphorylation of extracellular signal-regulated kinases 1/2 (Erk1/2).  Inhibition of p38 with SB202190 or JNK with SP600125 attenuated CPT-induced cell death.  Similarly, silencing p38 or c-Jun also in part prevented CPT-induced cell death.  In contrast, expression of constitutively active mitogen-activated protein kinase kinase 1 (MKK1) conferred resistance to CPT inhibition of Erk1/2 phosphorylation and induction of cell death.  Furthermore, we found that all of these were attributed to CPT induction of reactive oxygen species (ROS).  This is evidenced by the findings that CPT induced ROS in a concn.- and time-dependent manner; CPT induction of ROS was inhibited by N-acetyl-L-cysteine (NAC), a ROS scavenger; and NAC attenuated CPT activation of p38/JNK, inhibition of Erk1/2, and induction of cell death.  The results suggested that CPT induction of ROS activates p38/JNK and inhibits Erk1/2, leading to caspase-independent cell death in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTBGiAbYTCbVg90H21EOLACvtfcHk0lg4_yVIW61tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2iu78%253D&md5=27e1c6ae734312394d597063e8ea98cd</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-11-0551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-11-0551%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DOdaka%26aufirst%3DY.%26aulast%3DAwate%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCryptotanshinone%2520activates%2520p38%252FJNK%2520and%2520inhibits%2520Erk1%252F2%2520leading%2520to%2520caspase-independent%2520cell%2520death%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2012%26volume%3D5%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lhtEP_KTxWHOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7396</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800229d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7396-7404&author=W.+M.+Yuauthor=O.+Guvenchauthor=A.+D.+Mackerellauthor=C.+K.+Qu&title=Identification+of+small+molecular+weight+inhibitors+of+Src+homology+2+domain-containing+tyrosine+phosphatase+2+%28SHP-2%29+via+in+silico+database+screening+combined+with+experimental+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Small Molecular Weight Inhibitors of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 (SHP-2) via in Silico Database Screening Combined with Experimental Assay</span></div><div class="casAuthors">Yu, Wen-Mei; Guvench, Olgun; MacKerell, Alexander D.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7396-7404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening methods combined with exptl. assays were used to identify low mol. wt. inhibitors for Src homol. 2 domain-contg. phosphatase 2 (SHP-2) that is mutated and hyperactivated in Noonan syndrome and a significant portion of childhood leukemias.  Virtual screening included multiple conformations of the protein, score normalization procedures, and chem. similarity considerations.  As the catalytic core of SHP-2 shares extremely high homol. to those of the related SHP-1 phosphatase and other tyrosine phosphatases, in order to identify selective inhibitors, we chose to target an adjacent protein surface pocket that is predicted to be important for binding to phosphopeptides and that has structural features unique to SHP-2.  From a database of 1.3 million compds., 9 out of 165 computationally selected compds. were shown to inhibit SHP-2 activity with IC50 values of ≈ 100 μM.  Two of the active compds. were further verified for their ability to inhibit SHP-2-mediated cellular functions.  Fluorescence titrn. expts. confirmed their direct binding to SHP-2.  Because of their simple chem. structures, these small org. compds. have the potential to act as lead compds. for the development of novel anti-SHP-2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Kw_2kNl-RbVg90H21EOLACvtfcHk0lhtEP_KTxWHOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI&md5=915691bc2e64243286cf305314b3a470</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm800229d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800229d%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520small%2520molecular%2520weight%2520inhibitors%2520of%2520Src%2520homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520%2528SHP-2%2529%2520via%2520in%2520silico%2520database%2520screening%2520combined%2520with%2520experimental%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7396%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoqin Wu, Gang Xu, Xiaobo Li, Weiren Xu, Qianjin Li, Wei Liu, Karen A. Kirby, Mignon L. Loh, Jun Li, Stefan G. Sarafianos, <span class="NLM_string-name hlFld-ContribAuthor">Cheng-Kui Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1125-1137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00513" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00513%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitor%252Bthat%252BStabilizes%252Bthe%252BAutoinhibited%252BConformation%252Bof%252Bthe%252BOncogenic%252BTyrosine%252BPhosphatase%252BSHP2%26aulast%3DWu%26aufirst%3DXiaoqin%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01042018%26date%3D05122018%26date%3D20112018%26volume%3D62%26issue%3D3%26spage%3D1125%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dexter
C. Davis, Dominic G. Hoch, Li Wu, Daniel Abegg, Brandon S. Martin, Zhong-Yin Zhang, Alexander Adibekian, <span class="NLM_string-name hlFld-ContribAuthor">Mingji Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis, Biological Evaluation, and Target Identification of Rare Abies Sesquiterpenoids. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (50)
                                     , 17465-17473. <a href="https://doi.org/10.1021/jacs.8b07652" title="DOI URL">https://doi.org/10.1021/jacs.8b07652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b07652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b07652%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DTotal%252BSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BTarget%252BIdentification%252Bof%252BRare%252BAbies%252BSesquiterpenoids%26aulast%3DDavis%26aufirst%3DDexter%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24072018%26date%3D06122018%26date%3D21112018%26volume%3D140%26issue%3D50%26spage%3D17465%26epage%3D17473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qiong Wu, Kangdi Zheng, Xiaoting Huang, Li Li, <span class="NLM_string-name hlFld-ContribAuthor">Wenjie Mei</span>. </span><span class="cited-content_cbyCitation_article-title">Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10488-10501. <a href="https://doi.org/10.1021/acs.jmedchem.8b01018" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTanshinone-IIA-Based%252BAnalogues%252Bof%252BImidazole%252BAlkaloid%252BAct%252Bas%252BPotent%252BInhibitors%252BTo%252BBlock%252BBreast%252BCancer%252BInvasion%252Band%252BMetastasis%252Bin%252BVivo%26aulast%3DWu%26aufirst%3DQiong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27062018%26date%3D19112018%26date%3D06112018%26volume%3D61%26issue%3D23%26spage%3D10488%26epage%3D10501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaojia  Si</span>, <span class="hlFld-ContribAuthor ">Shoulai  Gu</span>, <span class="hlFld-ContribAuthor ">Mingliang  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Haoyan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yanjia  Fang</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>, and <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10205-10219. <a href="https://doi.org/10.1021/acs.jmedchem.7b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BInhibitors%252Bof%252BSHP2%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BCancer%252BTreatment%26aulast%3DXie%26aufirst%3DJingjing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11102017%26date%3D07122017%26date%3D28122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10205%26epage%3D10219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Fan  Zeng</span>, <span class="hlFld-ContribAuthor ">Ruo-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Sijiu  Li</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Gunawan</span>, <span class="hlFld-ContribAuthor ">Brandon S.  Lane</span>, <span class="hlFld-ContribAuthor ">Raghuveer S.  Mali</span>, <span class="hlFld-ContribAuthor ">Xingjun  Li</span>, <span class="hlFld-ContribAuthor ">Rebecca J.  Chan</span>, <span class="hlFld-ContribAuthor ">Reuben  Kapur</span>, <span class="hlFld-ContribAuthor ">Clark D.  Wells</span>, and <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6594-6609. <a href="https://doi.org/10.1021/jm5006176" title="DOI URL">https://doi.org/10.1021/jm5006176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5006176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252BPotential%252Bof%252BTargeting%252Bthe%252BOncogenic%252BSHP2%252BPhosphatase%26aulast%3DZeng%26aufirst%3DLi-Fan%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D21042014%26date%3D28072014%26date%3D14082014%26date%3D08072014%26volume%3D57%26issue%3D15%26spage%3D6594%26epage%3D6609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhang-Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Hu</span>, <span class="hlFld-ContribAuthor ">Yuan-Min  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Lei  Meng</span>, <span class="hlFld-ContribAuthor ">Ting  Huang</span>, <span class="hlFld-ContribAuthor ">Song-Cheng  Ying</span>, <span class="hlFld-ContribAuthor ">Zhe  Jiang</span>, <span class="hlFld-ContribAuthor ">A-Man  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastrointestinal Oncology</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 693-705. <a href="https://doi.org/10.4251/wjgo.v13.i7.693" title="DOI URL">https://doi.org/10.4251/wjgo.v13.i7.693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4251/wjgo.v13.i7.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4251%2Fwjgo.v13.i7.693%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastrointestinal%2520Oncology%26atitle%3DCryptotanshinone%252Binhibits%252Bcytotoxin-associated%252Bgene%252BA-associated%252Bdevelopment%252Bof%252Bgastric%252Bcancer%252Band%252Bmucosal%252Berosions%26aulast%3DChen%26aufirst%3DZhang-Ming%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D693%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Nian</span>, <span class="hlFld-ContribAuthor ">Jinhao  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuanlin  Feng</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1645-1652. <a href="https://doi.org/10.1016/j.cclet.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsmall%252Bmolecule%252Binhibitor%252Btargeting%252BSHP2%252Bmutations%252Bfor%252Bthe%252Blung%252Bcarcinoma%26aulast%3DNian%26aufirst%3DQing%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D1645%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia P.  Vainonen</span>, <span class="hlFld-ContribAuthor ">Majid  Momeny</span>, <span class="hlFld-ContribAuthor ">Jukka  Westermarck</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable cancer phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2021,</strong> <em>13 </em>
                                    (588)
                                     , eabe2967. <a href="https://doi.org/10.1126/scitranslmed.abe2967" title="DOI URL">https://doi.org/10.1126/scitranslmed.abe2967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.abe2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.abe2967%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DDruggable%252Bcancer%252Bphosphatases%26aulast%3DVainonen%26aufirst%3DJulia%2BP.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D588%26spage%3Deabe2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Liu</span>, <span class="hlFld-ContribAuthor ">Shan  Gao</span>, <span class="hlFld-ContribAuthor ">Reham M.  Elhassan</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to overcome drug resistance using SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.037" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStrategies%252Bto%252Bovercome%252Bdrug%252Bresistance%252Busing%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DMeng%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youqi  Tao</span>, <span class="hlFld-ContribAuthor ">Jingfei  Xie</span>, <span class="hlFld-ContribAuthor ">Qinglu  Zhong</span>, <span class="hlFld-ContribAuthor ">Yongyao  Wang</span>, <span class="hlFld-ContribAuthor ">Shengnan  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Luo</span>, <span class="hlFld-ContribAuthor ">Fengcai  Wen</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xie</span>, <span class="hlFld-ContribAuthor ">Jiawei  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoou  Sun</span>, <span class="hlFld-ContribAuthor ">Houfang  Long</span>, <span class="hlFld-ContribAuthor ">Junfeng  Ma</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangang  Long</span>, <span class="hlFld-ContribAuthor ">Xianyang  Fang</span>, <span class="hlFld-ContribAuthor ">Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Guohui  Li</span>, <span class="hlFld-ContribAuthor ">Jiajie  Diao</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel partially open state of SHP2 points to a “multiple gear” regulation mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100538. <a href="https://doi.org/10.1016/j.jbc.2021.100538" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100538%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bnovel%252Bpartially%252Bopen%252Bstate%252Bof%252BSHP2%252Bpoints%252Bto%252Ba%252B%2525E2%252580%25259Cmultiple%252Bgear%2525E2%252580%25259D%252Bregulation%252Bmechanism%26aulast%3DTao%26aufirst%3DYouqi%26date%3D2021%26volume%3D296%26spage%3D100538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haonan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengquan  Gao</span>, <span class="hlFld-ContribAuthor ">Chunxiao  Meng</span>, <span class="hlFld-ContribAuthor ">Xiangqian  Li</span>, <span class="hlFld-ContribAuthor ">Dayong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor Binding Sites in the Protein Tyrosine Phosphatase SHP-2. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (11)
                                     , 1017-1030. <a href="https://doi.org/10.2174/1389557520666200303130833" title="DOI URL">https://doi.org/10.2174/1389557520666200303130833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557520666200303130833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557520666200303130833%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DInhibitor%252BBinding%252BSites%252Bin%252Bthe%252BProtein%252BTyrosine%252BPhosphatase%252BSHP-2%26aulast%3DZhang%26aufirst%3DHaonan%26date%3D2020%26volume%3D20%26issue%3D11%26spage%3D1017%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheisi F. L. S.  Rocha</span>, <span class="hlFld-ContribAuthor ">Carlos M. R.  Sant'Anna</span>. </span><span class="cited-content_cbyCitation_article-title">A procedure combining molecular docking and semiempirical method PM7 for identification of selective Shp2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers</span><span> <strong>2019,</strong> <em>110 </em>
                                    (11)
                                     <a href="https://doi.org/10.1002/bip.23320" title="DOI URL">https://doi.org/10.1002/bip.23320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.23320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.23320%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%26atitle%3DA%252Bprocedure%252Bcombining%252Bmolecular%252Bdocking%252Band%252Bsemiempirical%252Bmethod%252BPM7%252Bfor%252Bidentification%252Bof%252Bselective%252BShp2%252Binhibitors%26aulast%3DRocha%26aufirst%3DSheisi%2BF.%2BL.%2BS.%26date%3D2019%26date%3D2019%26volume%3D110%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlène  Niogret</span>, <span class="hlFld-ContribAuthor ">Walter  Birchmeier</span>, <span class="hlFld-ContribAuthor ">Greta  Guarda</span>. </span><span class="cited-content_cbyCitation_article-title">SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.02468" title="DOI URL">https://doi.org/10.3389/fimmu.2019.02468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.02468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.02468%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSHP-2%252Bin%252BLymphocytes%252527%252BCytokine%252Band%252BInhibitory%252BReceptor%252BSignaling%26aulast%3DNiogret%26aufirst%3DCharl%25C3%25A8ne%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Ma</span>, <span class="hlFld-ContribAuthor ">Shiya  Luo</span>, <span class="hlFld-ContribAuthor ">Lin  Zhou</span>, <span class="hlFld-ContribAuthor ">Zewei  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiao  Li</span>, <span class="hlFld-ContribAuthor ">Lin  Xu</span>, <span class="hlFld-ContribAuthor ">Baoyong  Gong</span>, <span class="hlFld-ContribAuthor ">Weiwei  Qi</span>, <span class="hlFld-ContribAuthor ">Ti  Zhou</span>, <span class="hlFld-ContribAuthor ">Xia  Yang</span>, <span class="hlFld-ContribAuthor ">Guoquan  Gao</span>, <span class="hlFld-ContribAuthor ">Wenjie  Mei</span>, <span class="hlFld-ContribAuthor ">Zhonghan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">TanshinoneⅡA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2019,</strong> <em>514 </em>
                                    (3)
                                     , 861-867. <a href="https://doi.org/10.1016/j.bbrc.2019.05.056" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.05.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.05.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DTanshinone%2525E2%252585%2525A1A%252Bphenanthroimidazole%252Bderivative%252Bpolarizes%252Bmacrophage%252Bto%252Bimprove%252Bmetabolic%252Bhomeostasis%26aulast%3DMa%26aufirst%3DLei%26date%3D2019%26volume%3D514%26issue%3D3%26spage%3D861%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arata  Tomiyama</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Kentaro  Mori</span>, <span class="hlFld-ContribAuthor ">Koichi  Ichimura</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (2)
                                     , 241. <a href="https://doi.org/10.3390/cancers11020241" title="DOI URL">https://doi.org/10.3390/cancers11020241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11020241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11020241%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DProtein%252BPhosphatases%2525E2%252580%252594A%252BTouchy%252BEnemy%252Bin%252Bthe%252BBattle%252BAgainst%252BGlioblastomas%25253A%252BA%252BReview%26aulast%3DTomiyama%26aufirst%3DArata%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D2%26spage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quanbo  Ji</span>, <span class="hlFld-ContribAuthor ">Dengbin  Qi</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Xu</span>, <span class="hlFld-ContribAuthor ">Yameng  Xu</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Goodman</span>, <span class="hlFld-ContribAuthor ">Lei  Kang</span>, <span class="hlFld-ContribAuthor ">Qi  Song</span>, <span class="hlFld-ContribAuthor ">Zhongyi  Fan</span>, <span class="hlFld-ContribAuthor ">William J.  Maloney</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Nucleic Acids</span><span> <strong>2018,</strong> <em>11 </em>, 170-179. <a href="https://doi.org/10.1016/j.omtn.2018.02.001" title="DOI URL">https://doi.org/10.1016/j.omtn.2018.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omtn.2018.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omtn.2018.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Nucleic%2520Acids%26atitle%3DCryptotanshinone%252BProtects%252BCartilage%252Bagainst%252BDeveloping%252BOsteoarthritis%252Bthrough%252Bthe%252BmiR-106a-5p%25252FGLIS3%252BAxis%26aulast%3DJi%26aufirst%3DQuanbo%26date%3D2018%26volume%3D11%26spage%3D170%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander J.  Hale</span>, <span class="hlFld-ContribAuthor ">Eline  ter Steege</span>, <span class="hlFld-ContribAuthor ">Jeroen  den Hertog</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in understanding the role of protein-tyrosine phosphatases in development and disease. </span><span class="cited-content_cbyCitation_journal-name">Developmental Biology</span><span> <strong>2017,</strong> <em>428 </em>
                                    (2)
                                     , 283-292. <a href="https://doi.org/10.1016/j.ydbio.2017.03.023" title="DOI URL">https://doi.org/10.1016/j.ydbio.2017.03.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ydbio.2017.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ydbio.2017.03.023%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopmental%2520Biology%26atitle%3DRecent%252Badvances%252Bin%252Bunderstanding%252Bthe%252Brole%252Bof%252Bprotein-tyrosine%252Bphosphatases%252Bin%252Bdevelopment%252Band%252Bdisease%26aulast%3DHale%26aufirst%3DAlexander%2BJ.%26date%3D2017%26volume%3D428%26issue%3D2%26spage%3D283%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoming  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Xinbin  Zhou</span>, <span class="hlFld-ContribAuthor ">Nanyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Qin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jinxiu  Yang</span>, <span class="hlFld-ContribAuthor ">Jin  Dai</span>, <span class="hlFld-ContribAuthor ">Haibing  Wang</span>, <span class="hlFld-ContribAuthor ">Shenjie  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Microvascular Research</span><span> <strong>2017,</strong> <em>111 </em>, 25-31. <a href="https://doi.org/10.1016/j.mvr.2016.12.011" title="DOI URL">https://doi.org/10.1016/j.mvr.2016.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mvr.2016.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mvr.2016.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrovascular%2520Research%26atitle%3DCryptotanshinone%252Binhibits%252BVEGF-induced%252Bangiogenesis%252Bby%252Btargeting%252Bthe%252BVEGFR2%252Bsignaling%252Bpathway%26aulast%3DXu%26aufirst%3DXiaoming%26date%3D2017%26volume%3D111%26spage%3D25%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuanqi  Ren</span>, <span class="hlFld-ContribAuthor ">Cui  Wang</span>, <span class="hlFld-ContribAuthor ">Binbin  Xie</span>, <span class="hlFld-ContribAuthor ">Linfeng  Hu</span>, <span class="hlFld-ContribAuthor ">Hui  Chai</span>, <span class="hlFld-ContribAuthor ">Lei  Ding</span>, <span class="hlFld-ContribAuthor ">Lihua  Tang</span>, <span class="hlFld-ContribAuthor ">Yongliang  Xia</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Dou</span>. </span><span class="cited-content_cbyCitation_article-title">Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>796 </em>, 233-241. <a href="https://doi.org/10.1016/j.ejphar.2016.11.046" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.11.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.11.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.11.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DTanshinone%252BIIA%252Binduced%252Bcell%252Bdeath%252Bvia%252BmiR30b-p53-PTPN11%25252FSHP2%252Bsignaling%252Bpathway%252Bin%252Bhuman%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DRen%26aufirst%3DXuanqi%26date%3D2017%26volume%3D796%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.A.E.  Irving</span>. </span><span class="cited-content_cbyCitation_article-title">The Biology, Prognostic Relevance, and Targeted Treatment of Ras Pathway–Positive Childhood Acute Lymphoblastic Leukemia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 61-78. <a href="https://doi.org/10.1016/B978-0-12-803505-4.00004-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-803505-4.00004-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803505-4.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803505-4.00004-7%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BBiology%25252C%252BPrognostic%252BRelevance%25252C%252Band%252BTargeted%252BTreatment%252Bof%252BRas%252BPathway%2525E2%252580%252593Positive%252BChildhood%252BAcute%252BLymphoblastic%252BLeukemia%26aulast%3DIrving%26aufirst%3DJ.A.E.%26date%3D2017%26spage%3D61%26epage%3D78%26pub%3DElsevier%26atitle%3DConquering%252BRAS%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Fan  Liang</span>, <span class="hlFld-ContribAuthor ">Bo  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongyi  Sun</span>, <span class="hlFld-ContribAuthor ">Tongdan  Xue</span>, <span class="hlFld-ContribAuthor ">Runlei  Yang</span>, <span class="hlFld-ContribAuthor ">Duqiang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of demethylincisterol A 3 as a selective inhibitor of protein tyrosine phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>795 </em>, 124-133. <a href="https://doi.org/10.1016/j.ejphar.2016.12.012" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DIdentification%252Bof%252Bdemethylincisterol%252BA%252B3%252Bas%252Ba%252Bselective%252Binhibitor%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BShp2%26aulast%3DChen%26aufirst%3DChuan%26date%3D2017%26volume%3D795%26spage%3D124%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Ming  Shi</span>, <span class="hlFld-ContribAuthor ">Zhe  Qiang</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Shan-Zhai  Shang</span>, <span class="hlFld-ContribAuthor ">Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Bao-Wen  Du</span>, <span class="hlFld-ContribAuthor ">Hui-Pan  Peng</span>, <span class="hlFld-ContribAuthor ">Xu  Ji</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Lie  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Plasiatine, an Unprecedented Indole–Phenylpropanoid Hybrid from Plantago asiatica as a Potent Activator of the Nonreceptor Protein Tyrosine Phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep24945" title="DOI URL">https://doi.org/10.1038/srep24945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep24945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep24945%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPlasiatine%25252C%252Ban%252BUnprecedented%252BIndole%2525E2%252580%252593Phenylpropanoid%252BHybrid%252Bfrom%252BPlantago%252Basiatica%252Bas%252Ba%252BPotent%252BActivator%252Bof%252Bthe%252BNonreceptor%252BProtein%252BTyrosine%252BPhosphatase%252BShp2%26aulast%3DGao%26aufirst%3DZhong-Hua%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Cao</span>, <span class="hlFld-ContribAuthor ">Siyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Cuicui  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Liang</span>, <span class="hlFld-ContribAuthor ">Leilei  Yan</span>, <span class="hlFld-ContribAuthor ">Duqiang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep17626" title="DOI URL">https://doi.org/10.1038/srep17626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep17626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep17626%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BInhibitor%252Bof%252Bthe%252BProtein%252BTyrosine%252BPhosphatase%252BShp2%26aulast%3DChen%26aufirst%3DChuan%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruifang  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Functions of Shp2 in cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2015,</strong> <em>19 </em>
                                    (9)
                                     , 2075-2083. <a href="https://doi.org/10.1111/jcmm.12618" title="DOI URL">https://doi.org/10.1111/jcmm.12618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.12618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DFunctions%252Bof%252BShp2%252Bin%252Bcancer%26aulast%3DZhang%26aufirst%3DJie%26date%3D2015%26date%3D2015%26volume%3D19%26issue%3D9%26spage%3D2075%26epage%3D2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-jun  He</span>, <span class="hlFld-ContribAuthor ">Zhi-hong  Yu</span>, <span class="hlFld-ContribAuthor ">Ruo-yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong-yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Protein tyrosine phosphatases as potential therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2014,</strong> <em>35 </em>
                                    (10)
                                     , 1227-1246. <a href="https://doi.org/10.1038/aps.2014.80" title="DOI URL">https://doi.org/10.1038/aps.2014.80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2014.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2014.80%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DProtein%252Btyrosine%252Bphosphatases%252Bas%252Bpotential%252Btherapeutic%252Btargets%26aulast%3DHe%26aufirst%3DRong-jun%26date%3D2014%26date%3D2014%26volume%3D35%26issue%3D10%26spage%3D1227%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruolin  Yang</span>, <span class="hlFld-ContribAuthor ">Yang  Lu</span>, <span class="hlFld-ContribAuthor ">Jianhua  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of tanshinone IIA as a natural monoacylglycerol lipase inhibitor by combined
              in silico
              and
              in vitro
              approach. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1528-1532. <a href="https://doi.org/10.1039/C4MD00186A" title="DOI URL">https://doi.org/10.1039/C4MD00186A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00186A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00186A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Btanshinone%252BIIA%252Bas%252Ba%252Bnatural%252Bmonoacylglycerol%252Blipase%252Binhibitor%252Bby%252Bcombined%252Bin%252Bsilico%252Band%252Bin%252Bvitro%252Bapproach%26aulast%3DYang%26aufirst%3DRuolin%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D10%26spage%3D1528%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sam  Butterworth</span>, <span class="hlFld-ContribAuthor ">Michael  Overduin</span>, <span class="hlFld-ContribAuthor ">Alastair J  Barr</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1423-1437. <a href="https://doi.org/10.4155/fmc.14.88" title="DOI URL">https://doi.org/10.4155/fmc.14.88</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.88%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Bfor%252Btherapeutic%252Bintervention%26aulast%3DButterworth%26aufirst%3DSam%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1423%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Knight</span>, <span class="hlFld-ContribAuthor ">Julie Anne Elizabeth  Irving</span>. </span><span class="cited-content_cbyCitation_article-title">Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2014,</strong> <em>4 </em><a href="https://doi.org/10.3389/fonc.2014.00160" title="DOI URL">https://doi.org/10.3389/fonc.2014.00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2014.00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2014.00160%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DRas%25252FRaf%25252FMEK%25252FERK%252BPathway%252BActivation%252Bin%252BChildhood%252BAcute%252BLymphoblastic%252BLeukemia%252Band%252BIts%252BTherapeutic%252BTargeting%26aulast%3DKnight%26aufirst%3DThomas%26date%3D2014%26date%3D2014%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elaine  Xu</span>, <span class="hlFld-ContribAuthor ">Michael  Schwab</span>, <span class="hlFld-ContribAuthor ">André  Marette</span>. </span><span class="cited-content_cbyCitation_article-title">Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. </span><span class="cited-content_cbyCitation_journal-name">Reviews in Endocrine and Metabolic Disorders</span><span> <strong>2014,</strong> <em>15 </em>
                                    (1)
                                     , 79-97. <a href="https://doi.org/10.1007/s11154-013-9282-4" title="DOI URL">https://doi.org/10.1007/s11154-013-9282-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11154-013-9282-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11154-013-9282-4%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520Endocrine%2520and%2520Metabolic%2520Disorders%26atitle%3DRole%252Bof%252Bprotein%252Btyrosine%252Bphosphatases%252Bin%252Bthe%252Bmodulation%252Bof%252Binsulin%252Bsignaling%252Band%252Btheir%252Bimplication%252Bin%252Bthe%252Bpathogenesis%252Bof%252Bobesity-linked%252Binsulin%252Bresistance%26aulast%3DXu%26aufirst%3DElaine%26date%3D2014%26date%3D2013%26volume%3D15%26issue%3D1%26spage%3D79%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping-ping  Sun</span>, <span class="hlFld-ContribAuthor ">Fang  Yuan</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Ke  Sai</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Su  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptotanshinone Ameliorates Hepatic Normothermic Ischemia and Reperfusion Injury in Rats by Anti-mitochondrial Apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Biological and Pharmaceutical Bulletin</span><span> <strong>2014,</strong> <em>37 </em>
                                    (11)
                                     , 1758-1765. <a href="https://doi.org/10.1248/bpb.b14-00389" title="DOI URL">https://doi.org/10.1248/bpb.b14-00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.b14-00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.b14-00389%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DCryptotanshinone%252BAmeliorates%252BHepatic%252BNormothermic%252BIschemia%252Band%252BReperfusion%252BInjury%252Bin%252BRats%252Bby%252BAnti-mitochondrial%252BApoptosis%26aulast%3DSun%26aufirst%3DPing-ping%26date%3D2014%26volume%3D37%26issue%3D11%26spage%3D1758%26epage%3D1765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of cryptotanshinone as an inhibitor of SHP2. (A) Chemical structure of cryptotanshinone. (B) Phosphatase assays were carried out using the indicated phosphatases as enzymes and a phospho-EGFR peptide as the substrate in the presence of various concentrations of cryptotanshinone, as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For IC<sub>50</sub> determinations, six concentrations of cryptotanshinone were tested. Results shown are the mean ± SEM of three independent experiments. (C) PTP activities of the SHP2 PTP domain, WT full length SHP2, and full length SHP2 E76K were determined in the presence of cryptotanshinone at the indicated concentrations using a phospho-EGFR peptide as the substrate. Experiments were repeated three times. Similar results were obtained in each. Results shown are the mean ± SEM of triplicates from one experiment. Shown on the right panel are purified recombinant proteins stained with Coomassie blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cryptotanshinone directly binds to the SHP2 protein and functions as a mixed-type inhibitor. (A) Enzymatic kinetic analyses in the presence or absence of cryptotanshinone (25 μM) were performed using GST-SHP2 PTP (1.0 μg) as the enzyme. <i>V</i><sub>max</sub>, <i>K</i><sub>cat</sub>, and <i>K</i><sub>m</sub> values in the absence or presence of this inhibitor were determined. Results shown in the table are the mean ± SEM of three independent experiments. (B) Fluorescence titration of SHP2 was performed by increasing the concentrations of cryptotanshinone while maintaining the SHP2 protein concentration (1.0 μg). The fluorescence is plotted against the log concentration in mol/L (log [M]) for the compound. Experiments were repeated twice. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cryptotanshinone inhibits SHP2-mediated IL-3 signaling and IL-3-induced cellular responses. (A) Ba/F3 cells were cultured in IL-3 (1.0 ng/mL) containing medium supplemented with cryptotanshinone at the indicated concentrations or control DMSO. Cell numbers were determined 48 h later using the one solution cell proliferation assay kit. Experiments were performed three times with similar results obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment. (B) Ba/F3 cells were deprived of IL-3 overnight. Cells were treated with cryptotanshinone (20 μM) for 3 h and then stimulated with IL-3 (1.0 ng/mL) for the indicated times. (C) Ba/F3 cells were deprived of IL-3 overnight. Cells were treated with cryptotanshinone at the indicated concentrations for 3 h and then stimulated with IL-3 (1.0 ng/mL) for 10 min. Whole cell lysates were prepared. The levels of p-Erk, p-Akt, p-Jak2, and p-Stat5 were determined by immunoblotting analyses. Blots were striped and reprobed with anti-Erk, anti-Akt, anti-Jak2, and anti-Stat5 antibodies to check for protein loading. Experiments were repeated three times. Representative results from one experiment are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of cryptotanshinone are decreased in SHP2 knockdown cells. HeLa cells were transfected with control or SHP2 siRNA (400 pmol/8.0 × 10<sup>5</sup> cells). Forty-eight hours later, transfected cells were treated with cryptotanshinone at the indicated concentrations. Cell numbers were determined 24 h after the treatment. Cryptotanshinone or DMSO-treated knock-down and control cells were normalized against untreated knock-down and controls cells, respectively. SHP2 levels in knockdown and control cells were analyzed by immunoblotting analyses with anti-SHP2 antibody. Blots were stripped and reprobed with anti β-actin antibody to monitor protein loading. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mutant cells harboring hyperactivated SHP2 are more sensitive to cryptotanshinone. (A) WT and <i>PTPN11</i><sup><i>E76K/+</i></sup> MEFs were cultured in 10% FBS-containing DMEM supplemented with cryptotanshinone (20 μM). Cell numbers were determined using the one solution cell proliferation assay kit. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SEM of triplicates from one representative experiment. (B) Bone marrow cells harvested from <i>PTPN11</i><sup><i>E76K/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> and <i>PTPN11</i><sup><i>+/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> mice were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Colonies were enumerated 7 days later and normalized against the number of colonies derived from WT control cells treated with control DMSO. Representative results from two independent experiments are shown. Data are presented as the mean ± SEM of triplicates. (C) Bone marrow cells or splenocytes from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Colonies were enumerated 14 days later and normalized against the number of colonies derived from the cells treated with DMSO. Three patient samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one patient sample. (D) Bone marrow cells or splenocytes from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation were cultured in RPMI 1640 medium containing GM-CSF (1.0 ng/mL) and cryptotanshinone at the indicated concentrations or control DMSO. Total cell numbers were determined and normalized against the number of the cells treated with DMSO. Three patient samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one patient sample. (E) Human lymphoma cell line U937 with the <i>PTPN11</i><sup><i>G60R/+</i></sup> mutation and human lung cancer cell line H661 with the <i>PTPN11</i><sup><i>N58S/+</i></sup> mutation were incubated with cryptotanshinone at the indicated concentrations for 48 h. DMSO-treated cells were included as negative controls. Cell numbers were determined using the one solution cell proliferation assay kit. Experiments were repeated three times. Similar results were obtained in each. Data are presented as the mean ± SEM of triplicates from one representative experiment. (F) U937 cells were incubated with cryptotanshinone at the indicated concentrations. Apoptotic cells were quantified 24 h later by FACS using an annexin V staining kit following the instructions provided by the manufacturer. Cell cycle changes were determined by propidium iodide staining followed by FACS analyses 48 h later. Experiments were performed three times. Data presented on the left panel are the mean ± SEM of three experiments. Cell cycle profiles shown on the right panel are representatives of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/medium/jm-2013-00474r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of SHP2 and SHP1 by cryptotanshinone derivatives. (A) Chemical structures of tanshinone I, dihydrotanshinone, tanshinone IIA. (B) Phosphatase assays were carried out using the indicated phosphatases as enzymes and a phospho-EGFR peptide as the substrate in the presence of various concentrations of the compounds, as described in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B. For IC<sub>50</sub> determinations, five concentrations of the compounds were tested. Results shown are the mean ± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400474r/production/images/large/jm-2013-00474r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400474r&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtiss, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Beau, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-2331&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0lj979WyKHeAYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vattikuti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerbing, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonzo, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshinchi, S.</span><span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1831</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-1834&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchi&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masera, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-313&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0lh7qkxne9SbgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lh7qkxne9SbgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahlen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lh7qkxne9SbgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bentires-Alj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0ljJz_LJsD9buQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljJz_LJsD9buQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flotho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliegauf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archambeault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullighan, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstraesser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueso-Ramos, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Heuvel-Eibrink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zecca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span> </span><span class="NLM_article-title">Mutations in CBL occur frequently in juvenile myelomonocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1859-1863&author=M.+L.+Lohauthor=D.+S.+Sakaiauthor=C.+Flothoauthor=M.+Kangauthor=M.+Fliegaufauthor=S.+Archambeaultauthor=C.+G.+Mullighanauthor=L.+Chenauthor=E.+Bergstraesserauthor=C.+E.+Bueso-Ramosauthor=P.+D.+Emanuelauthor=H.+Hasleauthor=J.+P.+Issaauthor=M.+M.+van+den+Heuvel-Eibrinkauthor=F.+Locatelliauthor=J.+Staryauthor=M.+Treboauthor=M.+Wlodarskiauthor=M.+Zeccaauthor=K.+M.+Shannonauthor=C.+M.+Niemeyer&title=Mutations+in+CBL+occur+frequently+in+juvenile+myelomonocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DSakai%26aufirst%3DD.%2BS.%26aulast%3DFlotho%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DFliegauf%26aufirst%3DM.%26aulast%3DArchambeault%26aufirst%3DS.%26aulast%3DMullighan%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBergstraesser%26aufirst%3DE.%26aulast%3DBueso-Ramos%26aufirst%3DC.%2BE.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DIssa%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bden%2BHeuvel-Eibrink%26aufirst%3DM.%2BM.%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DStary%26aufirst%3DJ.%26aulast%3DTrebo%26aufirst%3DM.%26aulast%3DWlodarski%26aufirst%3DM.%26aulast%3DZecca%26aufirst%3DM.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26atitle%3DMutations%2520in%2520CBL%2520occur%2520frequently%2520in%2520juvenile%2520myelomonocytic%2520leukemia%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1859%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Muramatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankowska, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzolli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciejewski, J. P.</span><span> </span><span class="NLM_article-title">Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=1969-1975&author=H.+Muramatsuauthor=H.+Makishimaauthor=A.+M.+Jankowskaauthor=H.+Cazzolliauthor=C.+O%E2%80%99Keefeauthor=N.+Yoshidaauthor=Y.+Xuauthor=N.+Nishioauthor=A.+Hamaauthor=H.+Yagasakiauthor=Y.+Takahashiauthor=K.+Katoauthor=A.+Manabeauthor=S.+Kojimaauthor=J.+P.+Maciejewski&title=Mutations+of+an+E3+ubiquitin+ligase+c-Cbl+but+not+TET2+mutations+are+pathogenic+in+juvenile+myelomonocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuramatsu%26aufirst%3DH.%26aulast%3DMakishima%26aufirst%3DH.%26aulast%3DJankowska%26aufirst%3DA.%2BM.%26aulast%3DCazzolli%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DNishio%26aufirst%3DN.%26aulast%3DHama%26aufirst%3DA.%26aulast%3DYagasaki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DManabe%26aufirst%3DA.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DMaciejewski%26aufirst%3DJ.%2BP.%26atitle%3DMutations%2520of%2520an%2520E3%2520ubiquitin%2520ligase%2520c-Cbl%2520but%2520not%2520TET2%2520mutations%2520are%2520pathogenic%2520in%2520juvenile%2520myelomonocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D1969%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismat, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fnm1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15273746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=849-857&author=T.+Arakiauthor=M.+G.+Mohiauthor=F.+A.+Ismatauthor=R.+T.+Bronsonauthor=I.+R.+Williamsauthor=J.+L.+Kutokauthor=W.+Yangauthor=L.+I.+Paoauthor=D.+G.+Gillilandauthor=J.+A.+Epsteinauthor=B.+G.+Neel&title=Mouse+model+of+Noonan+syndrome+reveals+cell+type-+and+gene+dosage-dependent+effects+of+Ptpn11+mutation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span></div><div class="casAuthors">Araki, Toshiyuki; Mohi, M. Golam; Ismat, Fraz A.; Bronson, Roderick T.; Williams, Ifor R.; Kutok, Jeffery L.; Yang, Wentian; Pao, Lily I.; Gilliland, D. Gary; Epstein, Jonathan A.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-857</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Noonan syndrome is a common human autosomal dominant birth defect, characterized by short stature, facial abnormalities, heart defects and possibly increased risk of leukemia.  Mutations of Ptpn11 (also known as Shp2), which encodes the protein-tyrosine phosphatase Shp2, occur in ∼50% of individuals with Noonan syndrome, but their mol., cellular and developmental effects, and the relationship between Noonan syndrome and leukemia, are unclear.  We generated mice expressing the Noonan syndrome-assocd. mutant D61G.  When homozygous, the D61G mutant is embryonic lethal, whereas heterozygotes have decreased viability.  Surviving Ptpn11D61G/+ embryos (∼50%) have short stature, craniofacial abnormalities similar to those in Noonan syndrome, and myeloproliferative disease.  Severely affected Ptpn11D61G/+ embryos (∼50%) have multiple cardiac defects similar to those in mice lacking the Ras-GAP protein neurofibromin.  Their endocardial cushions have increased Erk activation, but Erk hyperactivation is cell and pathway specific.  Our results clarify the relationship between Noonan syndrome and leukemia and show that a single Ptpn11 gain-of-function mutation evokes all major features of Noonan syndrome by acting on multiple developmental lineages in a gene dosage-dependent and pathway-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmxo_WGTel7Vg90H21EOLACvtfcHk0liO_oDnToFmuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D&md5=69aae2a9730455356988fa32e7652c00</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnm1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1084%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DIsmat%26aufirst%3DF.%2BA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DEpstein%26aufirst%3DJ.%2BA.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMouse%2520model%2520of%2520Noonan%2520syndrome%2520reveals%2520cell%2520type-%2520and%2520gene%2520dosage-dependent%2520effects%2520of%2520Ptpn11%2520mutation%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2008-10-182626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=19179468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4414-4424&author=G.+Chanauthor=D.+Kalaitzidisauthor=T.+Usenkoauthor=J.+L.+Kutokauthor=W.+Yangauthor=M.+G.+Mohiauthor=B.+G.+Neel&title=Leukemogenic+Ptpn11+causes+fatal+myeloproliferative+disorder+via+cell-autonomous+effects+on+multiple+stages+of+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Usenko, Tatiana; Kutok, Jeffery L.; Yang, Wentian; Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4414-4424</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11, which encodes the tyrosine phosphatase SHP2, is mutated in approx. 35% of patients with juvenile myelomonocytic leukemia (JMML) and at a lower incidence in other neoplasms.  To model JMML pathogenesis, the authors generated knock-in mice that conditionally express the leukemia-assocd. mutant Ptpn11D61Y.  Expression of Ptpn11D61Y in all hematopoietic cells evokes a fatal myeloproliferative disorder (MPD), featuring leukocytosis, anemia, hepatosplenomegaly, and factor-independent colony formation by bone marrow (BM) and spleen cells.  The Lin-Sca1+cKit+ (LSK) compartment is expanded and "right-shifted," accompanied by increased stem cell factor (SCF)-evoked colony formation and Erk and Akt activation.  However, repopulating activity is decreased in diseased mice, and mice that do engraft with Ptpn11D61Y stem cells fail to develop MPD.  Ptpn11D61Y common myeloid progenitors (CMPs) and granulocyte-monocyte progenitors (GMPs) produce cytokine-independent colonies in a cell-autonomous manner and demonstrate elevated Erk and Stat5 activation in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation.  Ptpn11D61Y megakaryocyte-erythrocyte progenitors (MEPs) yield increased nos. of erythrocyte burst-forming units (BFU-Es), but MEPs and erythrocyte-committed progenitors (EPs) produce fewer erythrocyte colony-forming units (CFU-Es), indicating defective erythroid differentiation.  These studies provide a mouse model for Ptpn11-evoked MPD and show that this disease results from cell-autonomous and distinct lineage-specific effects of mutant Ptpn11 on multiple stages of hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cIq_57M9vrVg90H21EOLACvtfcHk0liO_oDnToFmuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D&md5=e5363cc8f6acc1716ae263e5fb6c4585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-10-182626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-10-182626%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DUsenko%26aufirst%3DT.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DLeukemogenic%2520Ptpn11%2520causes%2520fatal%2520myeloproliferative%2520disorder%2520via%2520cell-autonomous%2520effects%2520on%2520multiple%2520stages%2520of%2520hematopoiesis%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D4414%26epage%3D4424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">1977</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=1977-1988&author=D.+Xuauthor=X.+Liuauthor=W.+M.+Yuauthor=H.+J.+Meyersonauthor=C.+Guoauthor=S.+L.+Gersonauthor=C.+K.+Qu&title=Non-lineage%2Fstage-restricted+effects+of+a+gain-of-function+mutation+in+tyrosine+phosphatase+Ptpn11+%28Shp2%29+on+malignant+transformation+of+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DMeyerson%26aufirst%3DH.%2BJ.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DNon-lineage%252Fstage-restricted%2520effects%2520of%2520a%2520gain-of-function%2520mutation%2520in%2520tyrosine%2520phosphatase%2520Ptpn11%2520%2528Shp2%2529%2520on%2520malignant%2520transformation%2520of%2520hematopoietic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D1977%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0lhLBooHqBZhig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2F379277a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=8538796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=277-280&author=M.+J.+Eckauthor=S.+Pluskeyauthor=T.+Trubauthor=S.+C.+Harrisonauthor=S.+E.+Shoelson&title=Spatial+constraints+on+the+recognition+of+phosphoproteins+by+the+tandem+SH2+domains+of+the+phosphatase+SH-PTP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span></div><div class="casAuthors">Eck, Michael J.; Pluskey, Scott; Trub, Thomas; Harrison, Stephen C.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6562</span>),
    <span class="NLM_cas:pages">277-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The domain organization of many signaling proteins facilitates a segregation of binding, catalytic and regulatory functions.  The mammalian SH2 domain protein tyrosine phosphatases (PTPs) contain tandem SH2 domains and a single carboxy-terminal catalytic domain.  SH-PTP1 (PTP1C, HCP) and SH-PTP2 (Syp, PTP2C, PTP1D) function downstream from tyrosine kinase-linked insulin, growth factor, cytokine and antigen receptors.  As well as directing subcellular localization by binding to receptors and their substrates, the two SH2 domains of these PTPs function together to regulate catalysis.  Here the authors report the structure of the tandem SH2 domains of SH-PTP2 in complex with monophosphopeptides.  A fixed relative orientation of the two domains, stabilized by a disulfide bond and a small hydrophobic patch within the interface, separates the peptide binding sites by ∼ 40 Å.  The defined orientation of the SH2 domains in the structure, and data showing that peptide orientation and spacing between binding sites is crit. for enzymic activation, suggest that spatial constraints are important in this multidomain protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojp1hm-r1vcbVg90H21EOLACvtfcHk0lhLBooHqBZhig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D&md5=c4d7380b9e9f320a09cbec59a93673b8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F379277a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379277a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DT.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DSpatial%2520constraints%2520on%2520the%2520recognition%2520of%2520phosphoproteins%2520by%2520the%2520tandem%2520SH2%2520domains%2520of%2520the%2520phosphatase%2520SH-PTP2%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lhLBooHqBZhig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30984</span><span class="NLM_x">–</span> <span class="NLM_lpage">30993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-30993&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+McGregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0ljkU2rzEszbcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcGregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D30993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases in the JAK/STAT pathway</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4925</span><span class="NLM_x">–</span> <span class="NLM_lpage">4932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.2741%2F3051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18508557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=4925-4932&author=D.+Xuauthor=C.+K.+Qu&title=Protein+tyrosine+phosphatases+in+the+JAK%2FSTAT+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases in the JAK/STAT pathway</span></div><div class="casAuthors">Xu, Dan; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4925-4932</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in controlling cellular activities in response to extracellular cytokines.  Dysfunctions of the JAK/STAT pathway result in various hematopoietic and immune disorders.  The central events in regulating this pathway are tyrosine phosphorylation and dephosphorylation of the signaling components, which are carried out by protein tyrosine kinases and protein tyrosine phosphatases (PTP), resp.  Here, we review recent advances in the regulatory roles of PTPs, in particular, SHP2 phosphatase, in the JAK/STAT signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1iYtqQyD_7Vg90H21EOLACvtfcHk0ljkU2rzEszbcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D&md5=d3f84b6306220659ef34e4bf43cab87e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2741%2F3051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3051%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%2520in%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D4925%26epage%3D4932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljkU2rzEszbcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0ljkU2rzEszbcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The “Shp”ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%9CShp%E2%80%9Ding+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%259CShp%25E2%2580%259Ding%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">The molecular functions of Shp2 in the Ras/mitogen-activated protein kinase (ERK1/2) pathway</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2Fj.cellsig.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17993263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=453-459&author=M.+Danceauthor=A.+Montagnerauthor=J.+P.+Sallesauthor=A.+Yartauthor=P.+Raynal&title=The+molecular+functions+of+Shp2+in+the+Ras%2Fmitogen-activated+protein+kinase+%28ERK1%2F2%29+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</span></div><div class="casAuthors">Dance, Marie; Montagner, Alexandra; Salles, Jean-Pierre; Yart, Armelle; Raynal, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-459</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Shp2 is a ubiquitous tyrosine phosphatase contg. Src Homol. 2 domains which plays major biol. functions in response to various growth factors, hormones or cytokines.  This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway.  Recent progresses have been made in the understanding of the mol. mechanisms involved in this regulation.  We review here, and discuss the physiol. relevance, of the following mol. functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, neg. regulator of Sprouty, neg. regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2Kpmuyw1urVg90H21EOLACvtfcHk0lhCtHYtVIzmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCrsg%253D%253D&md5=a512a7f588e669c4ea4bb8fcc3d872db</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DDance%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DThe%2520molecular%2520functions%2520of%2520Shp2%2520in%2520the%2520Ras%252Fmitogen-activated%2520protein%2520kinase%2520%2528ERK1%252F2%2529%2520pathway%26jtitle%3DCell.%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Newman, D. J.</span><span> </span><span class="NLM_article-title">Natural products as leads to potential drugs: an old process or the new hope for drug discovery?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2589-2599&author=D.+J.+Newman&title=Natural+products+as+leads+to+potential+drugs%3A+an+old+process+or+the+new+hope+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0704090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704090%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%2520as%2520leads%2520to%2520potential%2520drugs%253A%2520an%2520old%2520process%2520or%2520the%2520new%2520hope%2520for%2520drug%2520discovery%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2589%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocchinfuso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeddu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palleschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucci, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1086%2F499925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=16358218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=279-290&author=M.+Tartagliaauthor=S.+Martinelliauthor=L.+Stellaauthor=G.+Bocchinfusoauthor=E.+Flexauthor=V.+Cordedduauthor=G.+Zampinoauthor=I.+Burgtauthor=A.+Palleschiauthor=T.+C.+Petrucciauthor=M.+Sorciniauthor=C.+Schochauthor=R.+Foaauthor=P.+D.+Emanuelauthor=B.+D.+Gelb&title=Diversity+and+functional+consequences+of+germline+and+somatic+PTPN11+mutations+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Stella, Lorenzo; Bocchinfuso, Gianfranco; Flex, Elisabetta; Cordeddu, Viviana; Zampino, Giuseppe; van der Burgt, Ineke; Palleschi, Antonio; Petrucci, Tamara C.; Sorcini, Mariella; Schoch, Claudia; Foa, Robin; Emanuel, Peter D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Germline mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome (NS) and the clin. related LEOPARD syndrome (LS), whereas somatic mutations in the same gene contribute to leukemogenesis.  On the basis of our previously gathered genetic and biochem. data, we proposed a model that splits NS- and leukemia-assocd. PTPN11 mutations into two major classes of activating lesions with differential perturbing effects on development and hematopoiesis.  To test this model, we investigated further the diversity of germline and somatic PTPN11 mutations, delineated the assocn. of those mutations with disease, characterized biochem. a panel of mutant SHP-2 proteins recurring in NS, LS, and leukemia, and performed mol. dynamics simulations to det. the structural effects of selected mutations.  Our results document a strict correlation between the identity of the lesion and disease and demonstrate that NS-causative mutations have less potency for promoting SHP-2 gain of function than do leukemia-assocd. ones.  Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxEltZHtDmELVg90H21EOLACvtfcHk0lhCtHYtVIzmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlGrtQ%253D%253D&md5=0831d0f9177ca5d3a5e20a4cf5bfe36c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1086%2F499925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F499925%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DStella%26aufirst%3DL.%26aulast%3DBocchinfuso%26aufirst%3DG.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBurgt%26aufirst%3DI.%26aulast%3DPalleschi%26aufirst%3DA.%26aulast%3DPetrucci%26aufirst%3DT.%2BC.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DSchoch%26aufirst%3DC.%26aulast%3DFoa%26aufirst%3DR.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DDiversity%2520and%2520functional%2520consequences%2520of%2520germline%2520and%2520somatic%2520PTPN11%2520mutations%2520in%2520human%2520disease%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2006%26volume%3D78%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawley, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">6004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5995-6004&author=W.+M.+Yuauthor=T.+S.+Hawleyauthor=R.+G.+Hawleyauthor=C.+K.+Qu&title=Catalytic-dependent+and+-independent+roles+of+SHP-2+tyrosine+phosphatase+in+interleukin-3+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DHawley%26aufirst%3DT.%2BS.%26aulast%3DHawley%26aufirst%3DR.%2BG.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DCatalytic-dependent%2520and%2520-independent%2520roles%2520of%2520SHP-2%2520tyrosine%2520phosphatase%2520in%2520interleukin-3%2520signaling%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D5995%26epage%3D6004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Emanuel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castleberry, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuckerman, K. S.</span><span> </span><span class="NLM_article-title">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=1704804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=925-929&author=P.+D.+Emanuelauthor=L.+J.+Batesauthor=R.+P.+Castleberryauthor=R.+J.+Gualtieriauthor=K.+S.+Zuckerman&title=Selective+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor+by+juvenile+chronic+myeloid+leukemia+hematopoietic+progenitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span></div><div class="casAuthors">Emanuel P D; Bates L J; Castleberry R P; Gualtieri R J; Zuckerman K S</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-9</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Juvenile chronic myelogenous leukemia (JCML) is a good model for the study of myeloproliferation because JCML hematopoietic progenitor cells grow in vitro at very low cell densities without the addition of exogenous stimulus.  Previous studies have demonstrated that this proliferation is dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF), and that removal of monocytes from the cell population before culture eliminates this "spontaneous" myeloproliferation, suggesting a paracrine role of monocyte stimulation.  However, subsequent studies have shown that increased GM-CSF production from the JCML monocytes is not a consistent finding and therefore not a plausible sole mechanism.  In examining hematopoietic growth factor dose-response curves, both JCML GM and erythroid nonadherent progenitor cell populations displayed a marked and selective hypersensitivity to GM-CSF.  Responses to interleukin-3 and G-CSF were identical to control dose-response curves.  This is the first demonstration of a myeloid leukemia in which hypersensitivity to a specific growth factor appears to be involved in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqJDPh116g5F1C8OJBvdfbfW6udTcc2ealqc8gHlLxfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D&md5=380f655a2c503367555ebf1d922e3697</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DBates%26aufirst%3DL.%2BJ.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DGualtieri%26aufirst%3DR.%2BJ.%26aulast%3DZuckerman%26aufirst%3DK.%2BS.%26atitle%3DSelective%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520by%2520juvenile%2520chronic%2520myeloid%2520leukemia%2520hematopoietic%2520progenitors%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26spage%3D925%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lyubynska, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauchle, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akutagawa, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, B. S.</span><span> </span><span class="NLM_article-title">A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">76ra27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1126%2Fscitranslmed.3001069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=76ra27&author=N.+Lyubynskaauthor=M.+F.+Gormanauthor=J.+O.+Lauchleauthor=W.+X.+Hongauthor=J.+K.+Akutagawaauthor=K.+Shannonauthor=B.+S.+Braun&title=A+MEK+inhibitor+abrogates+myeloproliferative+disease+in+Kras+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001069%26sid%3Dliteratum%253Aachs%26aulast%3DLyubynska%26aufirst%3DN.%26aulast%3DGorman%26aufirst%3DM.%2BF.%26aulast%3DLauchle%26aufirst%3DJ.%2BO.%26aulast%3DHong%26aufirst%3DW.%2BX.%26aulast%3DAkutagawa%26aufirst%3DJ.%2BK.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DBraun%26aufirst%3DB.%2BS.%26atitle%3DA%2520MEK%2520inhibitor%2520abrogates%2520myeloproliferative%2520disease%2520in%2520Kras%2520mutant%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D76ra27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munugalavadla, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorhorst, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span> </span><span class="NLM_article-title">Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3737</span><span class="NLM_x">–</span> <span class="NLM_lpage">3742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2004-10-4002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15644411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFejtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=3737-3742&author=R.+J.+Chanauthor=M.+B.+Leedyauthor=V.+Munugalavadlaauthor=C.+S.+Voorhorstauthor=Y.+Liauthor=M.+Yuauthor=R.+Kapur&title=Human+somatic+PTPN11+mutations+induce+hematopoietic-cell+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor</span></div><div class="casAuthors">Chan, Rebecca J.; Leedy, Melissa B.; Munugalavadla, Veerendra; Voorhorst, Cara S.; Li, Yanjun; Yu, Menggang; Kapur, Reuben</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3737-3742</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Juvenile myelomonocytic leukemia (JMML) is a lethal disease of young children characterized by hypersensitivity of hematopoietic progenitors to granulocyte-macrophage colony-stimulating factor (GM-CSF).  Mutations in PTPN11, which encodes the protein tyrosine phosphatase Shp-2, are common in JMML.  We hypothesized that PTPN11 mutations induce hypersensitivity of hematopoietic progenitors to GM-CSF and confer increased GM-CSF-stimulated phospho-extracellular signal-regulated kinase (Erk) levels.  To test this hypothesis, the wild-type (WT) and 3 mutant Ptpn11 cDNAs (E76K, D61V, and D61Y) were transduced into murine bone marrow cells to examine GM-CSF-stimulated granulocyte-macrophage colony-forming unit (CFU-GM) growth, macrophage progenitor proliferation, and activation of the Ras signaling pathway.  Expression of the Shp-2 mutants induced progenitor cell hypersensitivity to GM-CSF compared with cells transduced with vector alone or WT Shp-2.  Macrophage progenitors expressing the Shp-2 mutants displayed both basal and GM-CSF-stimulated hyperproliferation compared with cells transduced with vector alone or WT Shp-2.  Consistently, macrophage progenitors transduced with the Shp-2 mutants demonstrated constitutively elevated phospho-Erk levels and sustained activation of phospho-Erk following GM-CSF stimulation compared with vector alone or WT Shp-2.  These data support the hypothesis that PTPN11 mutations induce hematopoietic progenitor hypersensitivity to GM-CSF due to hyperactivation of the Ras signaling axis and provide a basis for the GM-CSF signaling pathway as a target for rational drug design in JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzelkPWl227Vg90H21EOLACvtfcHk0liDuVwjriMGfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFejtLY%253D&md5=3120af906beb1ae08c2b6717a6030235</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-4002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-4002%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DLeedy%26aufirst%3DM.%2BB.%26aulast%3DMunugalavadla%26aufirst%3DV.%26aulast%3DVoorhorst%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DKapur%26aufirst%3DR.%26atitle%3DHuman%2520somatic%2520PTPN11%2520mutations%2520induce%2520hematopoietic-cell%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D3737%26epage%3D3742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nishida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1111%2Fj.1349-7006.2003.tb01396.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=14662016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=1029-1033&author=K.+Nishidaauthor=T.+Hirano&title=The+role+of+Gab+family+scaffolding+adapter+proteins+in+the+signal+transduction+of+cytokine+and+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors</span></div><div class="casAuthors">Nishida, Keigo; Hirano, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  The Grb2-assocd. binder (Gab) family adapter proteins are scaffolding adapter mols. that display sequence similarity with Drosophila DOS (daughter of sevenless), which is a substrate for the protein tyrosine phosphatase Corkscrew.  Gab proteins contain a pleckstrin homol. (PH) domain and binding sites for SH2 and SH3 domains.  A no. of studies in multiple systems have implicated Gab in signaling via many different types of receptors, such as growth factor, cytokine, and antigen receptors, and via oncoproteins.  Recent studies of Gab1 and Gab2 knockout mice have clearly indicated an important role for Gabs in vivo.  Gab1-deficient mice die as embryos with multiple defects in placental, heart, skin, and muscle development.  Gab2-deficient mice are viable, but have a defect in the mast cell lineages and in allergic reactions.  Given the apparently central role played by Gab signaling via many receptors, delineating the precise mechanism(s) of Gab-mediated signaling is crit. to understanding how cytokines, growth factors, and oncoproteins mediate a variety of biol. activities: cell growth, differentiation, survival, and malignant transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvmpShz2VJB7Vg90H21EOLACvtfcHk0liDuVwjriMGfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSrtbk%253D&md5=00acec1b8b62f2a59fb671d6782452e2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01396.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01396.x%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DK.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520Gab%2520family%2520scaffolding%2520adapter%2520proteins%2520in%2520the%2520signal%2520transduction%2520of%2520cytokine%2520and%2520growth%2520factor%2520receptors%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The “Gab” in signal transduction</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1016%2FS0962-8924%2803%2900002-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12628344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1WqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=122-130&author=H.+Guauthor=B.+G.+Neel&title=The+%E2%80%9CGab%E2%80%9D+in+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Gab in signal transduction</span></div><div class="casAuthors">Gu, Haihua; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-130</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosine phosphorylation plays an important role in controlling cellular growth, differentiation, and function.  Abnormal regulation of tyrosine phosphorylation can result in human diseases such as cancer.  A major challenge of signal transduction research is to det. how the initial activation of protein-tyrosine kinases (PTKs) by extracellular stimuli triggers multiple downstream signaling cascades, which ultimately elicit diverse cellular responses.  Recent studies reveal that members of the Gab/Dos subfamily of scaffolding adaptor proteins (hereafter, Gab proteins) play a crucial role in transmitting key signals that control cell growth, differentiation, and function from multiple receptors.  Here, we review the structure, mechanism of action, and function of these interesting mols. in normal biol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtujtVbSiEF7Vg90H21EOLACvtfcHk0ljucylMqHMwDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1WqsLg%253D&md5=f8ada7e6a7fcf42c857b9b503a4fc7fa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900002-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900002-3%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520%25E2%2580%259CGab%25E2%2580%259D%2520in%2520signal%2520transduction%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D122%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Schubbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieuw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapp, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. M.</span><span> </span><span class="NLM_article-title">Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1182%2Fblood-2004-11-4207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=15761018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=311-317&author=S.+Schubbertauthor=K.+Lieuwauthor=S.+L.+Roweauthor=C.+M.+Leeauthor=X.+Liauthor=M.+L.+Lohauthor=D.+W.+Clappauthor=K.+M.+Shannon&title=Functional+analysis+of+leukemia-associated+PTPN11+mutations+in+primary+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells</span></div><div class="casAuthors">Schubbert, Suzanne; Lieuw, Kenneth; Rowe, Sara L.; Lee, Connie M.; Li, XiaXin; Loh, Mignon L.; Clapp, D. Wade; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11 encodes the protein tyrosine phosphatase SHP-2, which relays signals from growth factor receptors to Ras and other effectors.  Germline PTPN11 mutations underlie about 50% of Noonan syndrome (NS), a developmental disorder that is assocd. with an elevated risk of juvenile myelomonocytic leukemia (JMML).  Somatic PTPN11 mutations were recently identified in about 35% of patients with JMML; these mutations introduce amino acid substitutions that are largely distinct from those found in NS.  We assessed the functional consequences of leukemia-assocd. PTPN11 mutations in murine hematopoietic cells.  Expressing an E76K SHP-2 protein induced a hypersensitive pattern of granulocyte-macrophage colony-forming unit (CFU-GM) colony growth in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) that was dependent on SHP-2 catalytic activity.  E76K SHP-2 expression also enhanced the growth of immature progenitor cells with high replating potential, perturbed erythroid growth, and impaired normal differentiation in liq. cultures.  In addn., leukemia-assocd. SHP-2 mutations conferred a stronger phenotype than a germline mutation found in patients with NS.  Mutant SHP-2 proteins induce aberrant growth in multiple hematopoietic compartments, which supports a primary role of hyperactive Ras in the pathogenesis of JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodGp2TL7I53LVg90H21EOLACvtfcHk0ljucylMqHMwDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWjtrk%253D&md5=bb0309533d245fd69d069a8b69e67a35</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-11-4207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-11-4207%26sid%3Dliteratum%253Aachs%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DLieuw%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DFunctional%2520analysis%2520of%2520leukemia-associated%2520PTPN11%2520mutations%2520in%2520primary%2520hematopoietic%2520cells%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">5426</span><span class="NLM_x">–</span> <span class="NLM_lpage">5434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=5426-5434&author=W.+M.+Yuauthor=H.+Dainoauthor=J.+Chenauthor=K.+D.+Buntingauthor=C.+K.+Qu&title=Effects+of+a+leukemia-associated+gain-of-function+mutation+of+SHP-2+phosphatase+on+interleukin-3+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DDaino%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBunting%26aufirst%3DK.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DEffects%2520of%2520a%2520leukemia-associated%2520gain-of-function%2520mutation%2520of%2520SHP-2%2520phosphatase%2520on%2520interleukin-3%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D5426%26epage%3D5434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhou, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, M. S. S.</span><span> </span><span class="NLM_article-title">Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1177%2F0091270005282630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=16291709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1345-1359&author=L.+M.+Zhouauthor=Z.+Zuoauthor=M.+S.+S.+Chow&title=Danshen%3A+an+overview+of+its+chemistry%2C+pharmacology%2C+pharmacokinetics%2C+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use</span></div><div class="casAuthors">Zhou, Limin; Zuo, Zhong; Chow, Moses Sing Sum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1345-1359</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Danshen, the dried root of Salvia miltiorrhiza, has been widely used in China and, to a lesser extent, in Japan, the United States, and other European countries for the treatment of cardiovascular and cerebrovascular diseases.  In China, the specific clin. use is angina pectoris, hyperlipidemia, and acute ischemic stroke.  The current review covers its traditional uses, chem. constituents, pharmacol. activities, pharmacokinetics, clin. applications, and potential herb-drug interactions based on information obtained in both the English and Chinese literature.  Although numerous clin. trials have demonstrated that certain Danshen products in China are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality.  Therefore, large randomized clin. trials and further scientific research to det. its mechanism of actions will be necessary to ensure the safety, effectiveness, and better understanding of its action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSr_sWcH9VsbVg90H21EOLACvtfcHk0ljucylMqHMwDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjtrzL&md5=b2475589ba03dab9465808f6756dbce7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0091270005282630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270005282630%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%2BM.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DChow%26aufirst%3DM.%2BS.%2BS.%26atitle%3DDanshen%253A%2520an%2520overview%2520of%2520its%2520chemistry%252C%2520pharmacology%252C%2520pharmacokinetics%252C%2520and%2520clinical%2520use%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D45%26spage%3D1345%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foo, L. Y.</span><span> </span><span class="NLM_article-title">Polyphenolics of <i>Salvia</i>—a review</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=117-140&author=Y.+Luauthor=L.+Y.+Foo&title=Polyphenolics+of+Salvia%E2%80%94a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DFoo%26aufirst%3DL.%2BY.%26atitle%3DPolyphenolics%2520of%2520Salvia%25E2%2580%2594a%2520review%26jtitle%3DPhytochemistry%26date%3D2002%26volume%3D59%26spage%3D117%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Stickel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krahmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuppan, D.</span><span> </span><span class="NLM_article-title">Antifibrotic properties of botanicals in chronic liver disease</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=12143213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=1102-1108&author=F.+Stickelauthor=B.+Brinkhausauthor=N.+Krahmerauthor=H.+K.+Seitzauthor=E.+G.+Hahnauthor=D.+Schuppan&title=Antifibrotic+properties+of+botanicals+in+chronic+liver+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antifibrotic properties of botanicals in chronic liver disease</span></div><div class="casAuthors">Stickel, F.; Brinkhaus, B.; Kraehmer, N.; Seitz, H. K.; Hahn, E. G.; Schuppan, D.</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-Gastroenterology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">1102-1108</span>CODEN:
                <span class="NLM_cas:coden">HEGAD4</span>;
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    
            (<span class="NLM_cas:orgname">H.G.E. Update Medical Publishing</span>)
        </div><div class="casAbstract">A review.  Cirrhosis of the liver is a major complication of various chronic liver diseases and results from excess prodn. and decreased degrdn. of extracellular matrix.  Proinflammatory cytokines, toxic metabolites and certain drugs can trigger enhanced fibrogenesis in hepatic stellate cells and myofibroblasts, the major matrix-producing cells.  Since treatment of established cirrhosis is limited, therapeutic interventions that inhibit or mitigate fibrogenesis are needed.  Numerous drugs have been investigated for their antifibrotic potential and botanicals constitute a significant fraction of them.  Colchicine has been used to treat various chronic liver diseases with controversial results.  To date, there is a lack of studies in appropriate animal models and well-controlled human trials to demonstrate its antifibrotic properties.  Silymarin has so far failed to clearly show an antifibrotic effect in human studies, whereas animal expts. suggest that this mixt. of flavolignanes may be beneficial in patients which have not yet developed cirrhosis.  Animal studies indicate an antifibrotic potential of Shosaiko-to, a herbal combination frequently used in China and Japan for the treatment of chronic viral hepatitis, but mechanisms of action need to be further explored.  Other botanicals include trans-resveratrol, a flavonoid extd. from grapevine, and Salvia miltiorrhiza which were shown to interfere with the process of hepatic stellate cell activation.  Herbal combinations, such as compd. 861 and LIV.52 were advocated as antifibrotics or hepatoprotectives, but studies in humans have either been of questionable design or resulted in cessation of the trial due to adverse outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZF9BD30hxn7Vg90H21EOLACvtfcHk0lgTkFESueSo4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFOrurc%253D&md5=71d24dcb2fe5c21f2da189806abf6060</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStickel%26aufirst%3DF.%26aulast%3DBrinkhaus%26aufirst%3DB.%26aulast%3DKrahmer%26aufirst%3DN.%26aulast%3DSeitz%26aufirst%3DH.%2BK.%26aulast%3DHahn%26aufirst%3DE.%2BG.%26aulast%3DSchuppan%26aufirst%3DD.%26atitle%3DAntifibrotic%2520properties%2520of%2520botanicals%2520in%2520chronic%2520liver%2520disease%26jtitle%3DHepatogastroenterology%26date%3D2002%26volume%3D49%26spage%3D1102%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wojcikowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobe, G.</span><span> </span><span class="NLM_article-title">Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=160-166&author=K.+Wojcikowskiauthor=D.+W.+Johnsonauthor=G.+Gobe&title=Herbs+or+natural+substances+as+complementary+therapies+for+chronic+kidney+disease%3A+ideas+for+future+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWojcikowski%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BW.%26aulast%3DGobe%26aufirst%3DG.%26atitle%3DHerbs%2520or%2520natural%2520substances%2520as%2520complementary%2520therapies%2520for%2520chronic%2520kidney%2520disease%253A%2520ideas%2520for%2520future%2520studies%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2006%26volume%3D147%26spage%3D160%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowbay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. F.</span><span> </span><span class="NLM_article-title">Transport of cryptotanshinone, a major active triterpenoid in <i>Salvia miltiorrhiza</i> Bunge widely used in the treatment of stroke and Alzheimer’s disease, across the blood–brain barrier</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.2174%2F138920007780655441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=17504224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=365-377&author=X.+Y.+Yuauthor=S.+G.+Linauthor=X.+Chenauthor=Z.+W.+Zhouauthor=J.+Liangauthor=W.+Duanauthor=B.+Chowbayauthor=J.+Y.+Wenauthor=E.+Chanauthor=J.+Caoauthor=C.+G.+Liauthor=S.+F.+Zhou&title=Transport+of+cryptotanshinone%2C+a+major+active+triterpenoid+in+Salvia+miltiorrhiza+Bunge+widely+used+in+the+treatment+of+stroke+and+Alzheimer%E2%80%99s+disease%2C+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier</span></div><div class="casAuthors">Yu, Xi-Yong; Lin, Shu-Guang; Chen, Xiao; Zhou, Zhi-Wei; Liang, Jun; Duan, Wei; Chowbay, Balram; Wen, Jing-Yuan; Chan, Eli; Cao, Jie; Li, Chun-Guang; Zhou, Shu-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cryptotanshinone (CTS), a major constituent from the roots of Salvia miltiorrhiza (Danshen), is widely used in the treatment of coronary heart disease, stroke, and less commonly Alzheimer's disease.  Our recent study indicates that CTS is a substrate for P-glycoprotein (PgP/MDR1/ABCB1).  This study has investigated the nature of the brain distribution of CTS across the brain-blood barrier (BBB) using several in vitro and in vivo rodent models.  A polarized transport of CTS was found in rat primary microvascular endothelial cell (RBMVEC) monolayers, with facilitated efflux from the abluminal side to luminal side.  Addn. of a PgP (e.g. verapamil and quinidine) or multi-drug resistance protein 1/2 (MRP1/2) inhibitor (e.g. probenecid and MK-571) in both luminal and abluminal sides attenuated the polarized transport.  In a bilateral in situ brain perfusion model, the uptake of CTS into the cerebrum increased from 0.52% at 1 min to 11.13 mL/100 g tissue at 30 min and was significantly greater than that of sucrose.  Co-perfusion of a PgP/MDR1 (e.g. verapamil) or MRP1/2 inhibitor (e.g. probenecid) significantly increased the brain distribution of CTS by 35.1-163.6%.  The brain levels of CTS were only about 21% of those in blood plasma, and were significantly increased when coadministered with verapamil or probenecid in rats.  The brain levels of CTS in rats subjected to middle cerebral artery occlusion and rats treated with quinolinic acid (a neurotoxin) were about 2- to 2.5-fold higher than the control rats.  Moreover, the brain levels in mdr1a(-/-) and mrp1(-/-) mice were 10.9- and 1.5-fold higher than those in the wild-type mice, resp.  Taken collectively, these findings indicate that PgP and Mrp1 limit the brain penetration of CTS in rodents, suggesting a possible role of PgP and MRP1 in limiting the brain penetration of CTS in patients and causing drug resistance to Danshen therapy and interactions with conventional drugs that are substrates of PgP and MRP1.  Further studies are needed to explore the role of other drug transporters in restricting the brain penetration of CTS and the clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZbDUCmJDuPLVg90H21EOLACvtfcHk0lgTkFESueSo4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFehu7s%253D&md5=745d76a754cfea7c14b0a6d574ee0003</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F138920007780655441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780655441%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BY.%26aulast%3DLin%26aufirst%3DS.%2BG.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%2BW.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChowbay%26aufirst%3DB.%26aulast%3DWen%26aufirst%3DJ.%2BY.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%2BG.%26aulast%3DZhou%26aufirst%3DS.%2BF.%26atitle%3DTransport%2520of%2520cryptotanshinone%252C%2520a%2520major%2520active%2520triterpenoid%2520in%2520Salvia%2520miltiorrhiza%2520Bunge%2520widely%2520used%2520in%2520the%2520treatment%2520of%2520stroke%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D365%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Molecular evidence of cryptotanshinone for treatment and prevention of human cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=979-987&author=W.+Chenauthor=Y.+Luauthor=G.+Chenauthor=S.+Huang&title=Molecular+evidence+of+cryptotanshinone+for+treatment+and+prevention+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DMolecular%2520evidence%2520of%2520cryptotanshinone%2520for%2520treatment%2520and%2520prevention%2520of%2520human%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D979%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Shin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, B. M.</span><span> </span><span class="NLM_article-title">Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F0008-5472.CAN-08-2575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400474r&amp;key=19118003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=193-202&author=D.+S.+Shinauthor=H.+N.+Kimauthor=K.+D.+Shinauthor=Y.+J.+Yoonauthor=S.+J.+Kimauthor=D.+C.+Hanauthor=B.+M.+Kwon&title=Cryptotanshinone+inhibits+constitutive+signal+transducer+and+activator+of+transcription+3+function+through+blocking+the+dimerization+in+DU145+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells</span></div><div class="casAuthors">Shin, Dae-Seop; Kim, Hye-Nan; Shin, Ki Deok; Yoon, Young Ju; Kim, Seung-Jun; Han, Dong Cho; Kwon, Byoung-Mog</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-202</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Because signal transducer and activator of transcription 3 (STAT3) is constitutively activated in most human solid tumors and is involved in the proliferation, angiogenesis, immune evasion, and antiapoptosis of cancer cells, researchers have focused on STAT3 as a target for cancer therapy.  We screened for natural compds. that inhibit the activity of STAT3 using a dual-luciferase assay.  Cryptotanshinone was identified as a potent STAT3 inhibitor.  Cryptotanshinone rapidly inhibited STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells and the growth of the cells through 96 h of the treatment.  Inhibition of STAT3 Tyr705 phosphorylation in DU145 cells decreased the expression of STAT3 downstream target proteins such as cyclin D1, survivin, and Bcl-xL.  To investigate the cryptotanshinone inhibitory mechanism in DU145 cells, we analyzed proteins upstream of STAT3.  Although phosphorylation of Janus-activated kinase (JAK) 2 was inhibited by 7 μmol/L cryptotanshinone at 24 h, inhibition of STAT3 Tyr705 phosphorylation occurred within 30 min and the activity of the other proteins was not affected.  These results suggest that inhibition of STAT3 phosphorylation is caused by a JAK2-independent mechanism, with suppression of JAK2 phosphorylation as a secondary effect of cryptotanshinone treatment.  Continuing expts. revealed the possibility that cryptotanshinone might directly bind to STAT3 mols.  Cryptotanshinone was colocalized with STAT3 mols. in the cytoplasm and inhibited the formation of STAT3 dimers.  Computational modeling showed that cryptotanshinone could bind to the SH2 domain of STAT3.  These results suggest that cryptotanshinone is a potent anticancer agent targeting the activation STAT3 protein.  It is the first report that cryptotanshinone has antitumor activity through the inhibition of STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2CVvIW5pBbVg90H21EOLACvtfcHk0lj1LdHGtqS9zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCm&md5=f318d248355d742ef874136ccdc9c053</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2575%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DShin%26aufirst%3DK.%2BD.%26aulast%3DYoon%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DHan%26aufirst%3DD.%2BC.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26atitle%3DCryptotanshinone%2520inhibits%2520constitutive%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520function%2520through%2520blocking%2520the%2520dimerization%2520in%2520DU145%2520prostate%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D193%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F1940-6207.CAPR-10-0020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GrtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1015-1025&author=W.+Chenauthor=Y.+Luoauthor=L.+Liuauthor=H.+Zhouauthor=B.+Xuauthor=X.+Hanauthor=T.+Shenauthor=Z.+Liuauthor=Y.+Luauthor=S.+Huang&title=Cryptotanshinone+inhibits+cancer+cell+proliferation+by+suppressing+mammalian+target+of+rapamycin-mediated+cyclin+D1+expression+and+Rb+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation</span></div><div class="casAuthors">Chen, Wenxing; Luo, Yan; Liu, Lei; Zhou, Hongyu; Xu, Baoshan; Han, Xiuzhen; Shen, Tao; Liu, Zhijun; Lu, Yin; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1015-1025</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">Cryptotanshinone (CPT), a natural compd. isolated from the plant Salvia miltiorrhiza Bunge, is a potential anticancer agent.  However, little is known about its anticancer mechanism.  Here, we show that CPT inhibited cancer cell proliferation by arresting cells in G1-G0 phase of the cell cycle.  This is assocd. with the inhibition of cyclin D1 expression and retinoblastoma (Rb) protein phosphorylation.  Furthermore, we found that CPT inhibited the signaling pathway of the mammalian target of rapamycin (mTOR), a central regulator of cell proliferation.  This is evidenced by the findings that CPT inhibited type I insulin-like growth factor I- or 10% fetal bovine serum-stimulated phosphorylation of mTOR, p70 S6 kinase 1, and eukaryotic initiation factor 4E binding protein 1 in a concn.- and time-dependent manner.  Expression of constitutively active mTOR conferred resistance to CPT inhibition of cyclin D1 expression and Rb phosphorylation, as well as cell growth.  The results suggest that CPT is a novel anti-proliferative agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrnnLSnR0oLVg90H21EOLACvtfcHk0lj5DZUsLBVCPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GrtL3M&md5=bab2816a7bd03c86782446531f654b96</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-10-0020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-10-0020%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCryptotanshinone%2520inhibits%2520cancer%2520cell%2520proliferation%2520by%2520suppressing%2520mammalian%2520target%2520of%2520rapamycin-mediated%2520cyclin%2520D1%2520expression%2520and%2520Rb%2520phosphorylation%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2010%26volume%3D3%26spage%3D1015%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400474r&amp;key=10.1158%2F1940-6207.CAPR-11-0551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2iu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=778-787&author=W.+Chenauthor=L.+Liuauthor=Y.+Luoauthor=Y.+Odakaauthor=S.+Awateauthor=H.+Zhouauthor=T.+Shenauthor=S.+Zhengauthor=Y.+Luauthor=S.+Huang&title=Cryptotanshinone+activates+p38%2FJNK+and+inhibits+Erk1%2F2+leading+to+caspase-independent+cell+death+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells</span></div><div class="casAuthors">Chen, Wenxing; Liu, Lei; Luo, Yan; Odaka, Yoshinobu; Awate, Sanket; Zhou, Hongyu; Shen, Tao; Zheng, Shizhong; Lu, Yin; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">778-787</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cryptotanshinone (CPT), a natural compd. isolated from the plant Salvia miltiorrhiza Bunge, is a potential anticancer agent.  However, the underlying mechanism is not well understood.  Here, we show that CPT induced caspase-independent cell death in human tumor cells (Rh30, DU145, and MCF-7).  Besides downregulating antiapoptotic protein expression of survivin and Mcl-1, CPT increased phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (INK), and inhibited phosphorylation of extracellular signal-regulated kinases 1/2 (Erk1/2).  Inhibition of p38 with SB202190 or JNK with SP600125 attenuated CPT-induced cell death.  Similarly, silencing p38 or c-Jun also in part prevented CPT-induced cell death.  In contrast, expression of constitutively active mitogen-activated protein kinase kinase 1 (MKK1) conferred resistance to CPT inhibition of Erk1/2 phosphorylation and induction of cell death.  Furthermore, we found that all of these were attributed to CPT induction of reactive oxygen species (ROS).  This is evidenced by the findings that CPT induced ROS in a concn.- and time-dependent manner; CPT induction of ROS was inhibited by N-acetyl-L-cysteine (NAC), a ROS scavenger; and NAC attenuated CPT activation of p38/JNK, inhibition of Erk1/2, and induction of cell death.  The results suggested that CPT induction of ROS activates p38/JNK and inhibits Erk1/2, leading to caspase-independent cell death in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTBGiAbYTCbVg90H21EOLACvtfcHk0lj5DZUsLBVCPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2iu78%253D&md5=27e1c6ae734312394d597063e8ea98cd</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-11-0551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-11-0551%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DOdaka%26aufirst%3DY.%26aulast%3DAwate%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCryptotanshinone%2520activates%2520p38%252FJNK%2520and%2520inhibits%2520Erk1%252F2%2520leading%2520to%2520caspase-independent%2520cell%2520death%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2012%26volume%3D5%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lj5DZUsLBVCPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Yu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guvench, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7396</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800229d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400474r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7396-7404&author=W.+M.+Yuauthor=O.+Guvenchauthor=A.+D.+Mackerellauthor=C.+K.+Qu&title=Identification+of+small+molecular+weight+inhibitors+of+Src+homology+2+domain-containing+tyrosine+phosphatase+2+%28SHP-2%29+via+in+silico+database+screening+combined+with+experimental+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Small Molecular Weight Inhibitors of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 (SHP-2) via in Silico Database Screening Combined with Experimental Assay</span></div><div class="casAuthors">Yu, Wen-Mei; Guvench, Olgun; MacKerell, Alexander D.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7396-7404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening methods combined with exptl. assays were used to identify low mol. wt. inhibitors for Src homol. 2 domain-contg. phosphatase 2 (SHP-2) that is mutated and hyperactivated in Noonan syndrome and a significant portion of childhood leukemias.  Virtual screening included multiple conformations of the protein, score normalization procedures, and chem. similarity considerations.  As the catalytic core of SHP-2 shares extremely high homol. to those of the related SHP-1 phosphatase and other tyrosine phosphatases, in order to identify selective inhibitors, we chose to target an adjacent protein surface pocket that is predicted to be important for binding to phosphopeptides and that has structural features unique to SHP-2.  From a database of 1.3 million compds., 9 out of 165 computationally selected compds. were shown to inhibit SHP-2 activity with IC50 values of ≈ 100 μM.  Two of the active compds. were further verified for their ability to inhibit SHP-2-mediated cellular functions.  Fluorescence titrn. expts. confirmed their direct binding to SHP-2.  Because of their simple chem. structures, these small org. compds. have the potential to act as lead compds. for the development of novel anti-SHP-2 drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Kw_2kNl-RbVg90H21EOLACvtfcHk0lgRjNua4LAcRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOrsrfI&md5=915691bc2e64243286cf305314b3a470</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm800229d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800229d%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DGuvench%26aufirst%3DO.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520small%2520molecular%2520weight%2520inhibitors%2520of%2520Src%2520homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520%2528SHP-2%2529%2520via%2520in%2520silico%2520database%2520screening%2520combined%2520with%2520experimental%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7396%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP','PDB','2SHP'); return false;">PDB: 2SHP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/jm400474r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08785"></div></div></div></div></div><hr /></hr><p class="last">Figures S1–S7. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400474r/suppl_file/jm400474r_si_001.pdf">jm400474r_si_001.pdf (477.52 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400474r&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400474r%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400474r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f482cb701991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
